var title_f21_51_22320="Back pain in children and adolescents";
var content_f21_51_22320=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Back pain in children and adolescents (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?21/51/22320/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/51/22320/contributors\" id=\"au5578\">",
"       Peter A Nigrovic, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?21/51/22320/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/51/22320/contributors\" id=\"se6674\">",
"       Robert Sundel, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?21/51/22320/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/51/22320/contributors\" id=\"de5754\">",
"       Mary M Torchia, MD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"UTD.htm?21/51/22320?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      BACK PAIN OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     Back pain occurs commonly in children and adolescents, affecting up to 50 percent of children by age 18 to 20 years. The pain may be sharp and shooting, burning, or aching, and may be felt anywhere in the back.",
"    </p>",
"    <p>",
"     Although back pain may be a sign of a more concerning problem, especially in children younger than 10 years, most episodes of back pain in children are not serious and resolve without treatment.",
"    </p>",
"    <p>",
"     This topic will review the most common causes of back pain in children, treatments that can be tried at home, and a guide to when the child should see his or her healthcare provider. Back pain in adults is discussed separately. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?8/47/8950?source=see_link\">",
"      \"Patient information: Low back pain in adults (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      BACK PAIN CAUSES",
"     </span>",
"    </p>",
"    <p>",
"     The most common cause of low back pain in children is muscle sprain and strain. This can occur while playing, from carrying a heavy backpack, or after a fall.",
"    </p>",
"    <p>",
"     Less common causes include abnormalities in the spinal bones (vertebrae), infections, arthritis, and, rarely, cancer. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/45/19162?source=see_link\">",
"      \"Back pain in children and adolescents: Overview of causes\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H3\">",
"     <span class=\"h1\">",
"      WHEN TO SEEK HELP",
"     </span>",
"    </p>",
"    <p>",
"     Contact your child's healthcare provider if your child has one or more of the following:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Back pain that is severe, occurs at night or wakes the child from sleep, or worsens over time",
"      </li>",
"      <li>",
"       Back pain accompanied by fever (temperature &gt;100.4&ordm;F or 38&ordm;C)",
"      </li>",
"      <li>",
"       Back pain accompanied by weight loss",
"      </li>",
"      <li>",
"       Back pain in a child under five years of age",
"      </li>",
"      <li>",
"       Leg weakness, walking with a limp, or refusing to walk",
"      </li>",
"      <li>",
"       Back pain that developed after a recent injury",
"      </li>",
"      <li>",
"       Past history of cancer or tuberculosis",
"      </li>",
"      <li>",
"       Change in bowel or bladder control (eg, new accidents)",
"      </li>",
"      <li>",
"       Back pain that prevents the child from participating in normal activities",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H4\">",
"     <span class=\"h1\">",
"      BACK PAIN DIAGNOSIS",
"     </span>",
"    </p>",
"    <p>",
"     To determine the most likely cause of a child's back pain, the healthcare provider will ask questions and will perform a physical examination. Blood tests and x-rays or other imaging tests are not always needed, especially if the back pain began recently. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/39/2679?source=see_link\">",
"      \"Evaluation of the child with back pain\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H5\">",
"     <span class=\"h1\">",
"      BACK PAIN TREATMENT",
"     </span>",
"    </p>",
"    <p>",
"     If your child has back pain but has none of the warning signs described above (see",
"     <a class=\"local\" href=\"#H3\">",
"      'When to seek help'",
"     </a>",
"     above), it is reasonable to try some home treatments initially. However, if the child's pain does not improve, call the child's healthcare provider.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6\">",
"     <span class=\"h2\">",
"      Pain medications",
"     </span>",
"     &nbsp;&mdash;&nbsp;Non-prescription pain medications, such as acetaminophen (sample brand name: Tylenol&reg;) or ibuprofen (sample brand names: Advil&reg;, Motrin&reg;) may help to reduce a child's back pain. These medications are particularly helpful for back pain caused by overuse, strains, and sprains.",
"    </p>",
"    <p>",
"     These medications should be given according to the child's weight, rather than age.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h2\">",
"      Heat",
"     </span>",
"     &nbsp;&mdash;&nbsp;Applying heat can help with back pain during the first few days after overuse or an injury. You may use a heating pad, hot water bottle, or other hot pack. Be careful to avoid burning the skin with a pack or pad that is too hot.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H8\">",
"     <span class=\"h2\">",
"      Remaining active",
"     </span>",
"     &nbsp;&mdash;&nbsp;Staying active can help to relieve muscle spasms and prevents weakening of the muscles. On the other hand, back pain caused by overexertion may not improve without rest. Thus, high-impact activities (running, jumping, or other activities that cause pain) should be avoided while the child has pain. It is fine for the child to continue with regular day-to-day activities and light exercise that does not cause pain.",
"    </p>",
"    <p>",
"     Bed rest is not recommended. Children who prefer to remain completely inactive should be evaluated by a healthcare provider.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h2\">",
"      Stretching and strengthening exercises",
"     </span>",
"     &nbsp;&mdash;&nbsp;As the pain begins to improve, your child's healthcare provider may recommend specific stretching and strengthening exercises. A physical therapist can help to design a program tailored to your child.",
"    </p>",
"    <p>",
"     Activities such as walking, swimming, bicycling, and other low-impact activities are also recommended. The child should temporarily avoid activities that involve twisting or bending, are high impact, or that make the back hurt more.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H10\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your child's healthcare provider is the best source of information for questions and concerns related to your child's medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H2413532703\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H23443567\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?36/7/36978?source=see_link\">",
"      Patient information: Low back pain in adults (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?18/20/18754?source=see_link\">",
"      Patient information: Scoliosis (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H23443584\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?8/47/8950?source=see_link\">",
"      Patient information: Low back pain in adults (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/4/42057?source=see_link\">",
"      Approach to the child with a limp",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/45/19162?source=see_link\">",
"      Back pain in children and adolescents: Overview of causes",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/62/33770?source=see_link\">",
"      Clinical features; evaluation; and diagnosis of adolescent idiopathic scoliosis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/39/2679?source=see_link\">",
"      Evaluation of the child with back pain",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/9/23706?source=see_link\">",
"      Overview of the causes of limp in children",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/31/8696?source=see_link\">",
"      Spondyloarthropathy in children",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/12/37065?source=see_link\">",
"      Treatment and prognosis of adolescent idiopathic scoliosis",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       American Academy of Orthopaedic Surgeons",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://orthoinfo.aaos.org/topic.cfm?topic=A00036\">",
"      file://orthoinfo.aaos.org/topic.cfm?topic=A00036",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       <a class=\"external\" href=\"file://kidshealth.org/\">",
"        Kidshealth.org",
"       </a>",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://kidshealth.org/parent/positive/learning/backpack.html\">",
"      file://kidshealth.org/parent/positive/learning/backpack.html",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"UTD.htm?21/51/22320/abstract/1-3\">",
"      1-3",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 15, 2012.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"UTD.htm?21/51/22320?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     Backpack safety. American Academy of Pediatrics. Available at: www.aap.org/publiced/BR_Backpack.htm (Accessed on March 30, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22320/abstract/2\">",
"      Diepenmaat AC, van der Wal MF, de Vet HC, Hirasing RA. Neck/shoulder, low back, and arm pain in relation to computer use, physical activity, stress, and depression among Dutch adolescents. Pediatrics 2006; 117:412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22320/abstract/3\">",
"      Pellis&eacute; F, Balagu&eacute; F, Rajmil L, et al. Prevalence of low back pain and its effect on health-related quality of life in adolescents. Arch Pediatr Adolesc Med 2009; 163:65.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f21_51_22320=[""].join("\n");
var outline_f21_51_22320=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           BACK PAIN OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           BACK PAIN CAUSES",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H3\">",
"           WHEN TO SEEK HELP",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H4\">",
"           BACK PAIN DIAGNOSIS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H5\">",
"           BACK PAIN TREATMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H10\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f21_51_22321="Finger fx dislocation child";
var content_f21_51_22321=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F63865&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F63865&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Fracture dislocation of the metacarpal joint of the middle finger",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 444px; height: 320px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) A 9-year-old girl sustained this radial fracture-dislocation of the middle finger. B) Closed reduction restored joint and fracture alignment.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Kozin SH, Waters PM. Fractures and dislocations of the hand and carpus in children. In: Rockwood and Wilkins' Fractures in Children, 7th ed, Beaty JH, Kasser JR (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2010. Copyright &copy; 2010 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_51_22321=[""].join("\n");
var outline_f21_51_22321=null;
var title_f21_51_22322="tonsill";
var content_f21_51_22322=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"videoplayer\" h264=\"./images/CARD/59293/tonsill_conv.mp4?title=tonsill\" style=\"width:320px;height:256px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Coblation tonsillectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 358px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The coblation wand is used to dissect and remove the tonsil from its bed.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jose W Ruiz, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_51_22322=[""].join("\n");
var outline_f21_51_22322=null;
var title_f21_51_22323="MHC II ag process present";
var content_f21_51_22323=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F65035&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F65035&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    MHC class II antigen processing and presentation pathway",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 447px; height: 421px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This is a figure&nbsp;showing antigen processing and presentation via cells utilizing MHC class II. Initially, exogenous antigen is taken up and broken down by proteases (at acidic pH) into peptides in the endocytic compartment. MHC class II &alpha;&beta; heterodimers are assembled in the endoplasmic recticulum (ER) with the invariant chain (Ii) polypeptide. These complexes are targeted from the Golgi complex to the endocytic compartment by Ii, where they encounter peptides generated from exogenous antigen. Ii is degraded to the CLIP peptide by proteases at low pH, and CLIP exchange is facilitated by acidic conditions and catalyzed by HLA-DM. MHC II molecules that have stably bound new peptides are then exported to the cell surface for presentation to CD4+ T cells.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_51_22323=[""].join("\n");
var outline_f21_51_22323=null;
var title_f21_51_22324="Fixed subaortic stenosis";
var content_f21_51_22324=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F71372&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F71372&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Fixed subaortic stenosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 354px; height: 391px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Panel A: Three two dimensional images from a patient with fixed subvalvular stenosis. The stenosing tissue is easily overlooked, especially since the aortic valve itself is normal in its cross sectional appearance. Panel B: A three dimensional reconstruction of the subaortic membrane. This surface rendered reconstruction views the membrane from the left ventricular outflow tract (LVOT), looking toward the aortic valve. The membrane is much more complex and extensive that appreciated from a single two dimensional image.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Drs. Elyse Foster and Raymond Stainback.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_51_22324=[""].join("\n");
var outline_f21_51_22324=null;
var title_f21_51_22325="Molecular effects of inhaled glucocorticoid therapy in asthma";
var content_f21_51_22325=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Molecular effects of inhaled glucocorticoid therapy in asthma",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/51/22325/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/51/22325/contributors\">",
"     Peter J Barnes, DM, DSc, FRCP, FRS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/51/22325/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/51/22325/contributors\">",
"     Bruce S Bochner, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/51/22325/contributors\">",
"     Robert A Wood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/51/22325/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/51/22325/contributors\">",
"     Helen Hollingsworth, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/51/22325/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 10, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inhaled glucocorticoids (ie, glucocorticosteroids, corticosteroids, steroids) suppress airway inflammation by activating anti-inflammatory genes, switching off inflammatory gene expression, and inhibiting inflammatory cells. In addition, they enhance beta 2 adrenergic signaling by increasing beta 2-receptor expression and function. The net effect is control of the symptoms and signs of asthma in most patients.",
"   </p>",
"   <p>",
"    The molecular effects of inhaled glucocorticoids are discussed in this topic review. In addition, molecular determinants of glucocorticoid sensitivity are reviewed. The role of inhaled glucocorticoids in the management of asthma is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/42/23208?source=see_link\">",
"     \"Pharmacologic use of glucocorticoids\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/61/31703?source=see_link\">",
"     \"Determinants of glucocorticoid dosing\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/46/18154?source=see_link\">",
"     \"Treatment of intermittent and mild persistent asthma in adolescents and adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/7/26745?source=see_link\">",
"     \"Treatment of moderate persistent asthma in adolescents and adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/42/7849?source=see_link\">",
"     \"Glucocorticoid-resistant asthma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     SUPPRESSION OF INFLAMMATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Discoveries related to gene transcription have improved our understanding of the mechanisms by which inhaled glucocorticoids suppress airway inflammation [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22325/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. These mechanisms include anti-inflammatory gene activation and switching off inflammatory gene expression, which alter the expression of inflammatory and anti-inflammatory enzymes, receptors, cytokines, adhesion molecules, and chemokines. The net effect is decreased inflammatory cell recruitment, survival and accumulation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Anti-inflammatory gene activation",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two types of glucocorticoid receptors (GR), GR alpha and GR beta. Glucocorticoid action is facilitated by GR alpha, but inhibited by GR beta.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      GR alpha &ndash; Glucocorticoids passively diffuse across the cell membrane and bind to GR alpha in the cytoplasm [",
"      <a class=\"abstract\" href=\"UTD.htm?21/51/22325/abstract/1\">",
"       1",
"      </a>",
"      ]. The",
"      <span class=\"nowrap\">",
"       glucocorticoid/GR",
"      </span>",
"      alpha complex (ie, activated GR) rapidly translocates into the nucleus. There, the activated GR form dimers, which bind to glucocorticoid response elements (GREs) within the promoter of steroid-responsive genes. There are positive and negative GREs.",
"      <br/>",
"      <br/>",
"      Interaction with positive GREs stimulates gene transcription. Such genes usually encode anti-inflammatory proteins [",
"      <a class=\"abstract\" href=\"UTD.htm?21/51/22325/abstract/3\">",
"       3",
"      </a>",
"      ]. As an example, glucocorticoids stimulate expression of secretory leukoprotease inhibitor and mitogen-activated protein kinase phosphatase-1 (MKP-1), which inhibit mitogen-activated protein (MAP) kinase pathways (",
"      <a class=\"graphic graphic_figure graphicRef78772 \" href=\"UTD.htm?5/28/5573\">",
"       figure 1",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?21/51/22325/abstract/4\">",
"       4",
"      </a>",
"      ]. Interaction with positive GREs appears to account for most of the side effects of glucocorticoids [",
"      <a class=\"abstract\" href=\"UTD.htm?21/51/22325/abstract/5\">",
"       5",
"      </a>",
"      ]. As an example, binding the GR to the promoter site on the osteocalcin gene interferes with its transcription, resulting in reduced expression and reduction in bone synthesis.",
"      <br/>",
"      <br/>",
"      Interaction with negative GREs suppresses gene transcription, but there are only a few examples of reduced expression of inflammatory genes through interaction with negative GREs, indicating that other molecular mechanisms are involved in the suppression of inflammation.",
"     </li>",
"     <li>",
"      GR beta &ndash; GR beta is an alternatively spliced form of GR. It binds DNA, but not glucocorticoids. As a result, GR beta may act as an inhibitor of glucocorticoid action by antagonizing the binding of GR alpha dimers to DNA, although the amounts of GR beta are thought to be too small to cause significant inhibition of glucocorticoid effects [",
"      <a class=\"abstract\" href=\"UTD.htm?21/51/22325/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Switching off inflammatory genes",
"    </span>",
"    &nbsp;&mdash;&nbsp;In all inflammatory diseases, including asthma, many inflammatory genes are activated. These include genes that encode cytokines, chemokines, adhesion molecules, inflammatory enzymes, and receptors. Such genes are switched on when a coactivator molecule (eg, CREB-binding protein) binds to a proinflammatory transcription factor (eg, nuclear factor-kappa B [NF-kB], activator protein-1[AP-1]). The coactivator molecule then acetylates core histones, which opens the chromatin structure and allows transcription to proceed [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22325/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are several ways in which inhaled glucocorticoids interfere with this process and switch off the inflammatory cascade:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Glucocorticoids interact with the coactivator molecules and inhibit their binding to proinflammatory transcription factors [",
"      <a class=\"abstract\" href=\"UTD.htm?21/51/22325/abstract/2,8\">",
"       2,8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Activated GR recruit histone deacetylase-2 (HDAC2), which deacetylates core histones. HDAC2 has broad impact, suppressing all activated inflammatory genes within the nucleus (",
"      <a class=\"graphic graphic_figure graphicRef59432 \" href=\"UTD.htm?11/42/11940\">",
"       figure 2",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Regardless of the mechanism, the net effect is reduced histone acetylation, failure of the chromatin structure to open, and decreased transcription of inflammatory genes. Inhaled glucocorticoids preferentially impact inflammatory genes and do so primarily on a local level. Thus, they are effective at controlling asthma and are associated with few adverse effects.",
"   </p>",
"   <p>",
"    There may also be post-transcriptional mechanisms by which glucocorticoids switch off inflammation. As an example, some inflammatory genes (eg, granulocyte-macrophage colony stimulating factor) normally have an unstable messenger RNA that is rapidly degraded by RNAses. Inflammatory mediators stabilize this messenger RNA during inflammation. Glucocorticoids reverse this effect, allowing rapid degradation of mRNA and reduced inflammatory protein secretion [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22325/abstract/9\">",
"     9",
"    </a>",
"    ]. The mechanism of action is uncertain, but may be glucocorticoid-mediated inhibition of the proteins that stabilize mRNAs, such as tristetraprolin [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22325/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Further research is needed to determine which mechanisms are relevant in patients with asthma. There have been past examples of glucocorticoid-mediated effects that were detected experimentally, but could not subsequently be confirmed in patients. Specifically, the activated GR directly interacts with transcription factors and inhibits their activity in experimental systems, but not in patients with asthma [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22325/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Inflammatory cell inhibition",
"    </span>",
"    &nbsp;&mdash;&nbsp;By activating anti-inflammatory genes and switching off inflammatory gene expression, inhaled glucocorticoids inhibit inflammatory cell survival and suppress production of chemotactic mediators and adhesion molecules. The net effect is decreased mucosal inflammation, which is characterized by fewer inflammatory cells, including T lymphocytes, eosinophils, mast cells, and dendritic cells (",
"    <a class=\"graphic graphic_figure graphicRef70776 \" href=\"UTD.htm?12/30/12773\">",
"     figure 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Suppression of mucosal inflammation begins within hours of administration [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22325/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. As an example, in a double-blind crossover trial, 41 adults with stable asthma and at least 7 percent sputum eosinophilia were randomly assigned to receive a single dose of inhaled",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/7/32880?source=see_link\">",
"     budesonide",
"    </a>",
"    or placebo on two consecutive days [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22325/abstract/12\">",
"     12",
"    </a>",
"    ]. Budesonide decreased sputum eosinophilia within six hours.",
"   </p>",
"   <p>",
"    Decreased airway inflammation is associated with decreased airway responsiveness, which also begins within hours of inhaled glucocorticoid administration [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22325/abstract/12-14\">",
"     12-14",
"    </a>",
"    ]. As an example, in three randomized, controlled crossover trials,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/45/39632?source=see_link\">",
"     fluticasone",
"    </a>",
"    decreased airway responsiveness two- to three-fold within two hours [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22325/abstract/13\">",
"     13",
"    </a>",
"    ]. This effect may gradually increase over several months before reaching a plateau [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22325/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     BETA 2-RECEPTOR EFFECTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Suppression of airway inflammation is not the only way in which inhaled glucocorticoids reduce the symptoms and signs of asthma. They also enhance beta 2 adrenergic signaling by increasing beta 2-receptor expression and function.",
"   </p>",
"   <p>",
"    Inhaled beta 2-agonists and glucocorticoids are frequently used together in the management of asthma. It is now recognized that there are important molecular interactions between these two classes of medication [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22325/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. Specifically, glucocorticoids increase transcription of the gene encoding beta 2-receptors, inducing increased expression of beta 2-receptors on the cell surface [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22325/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. They also enhance the coupling of beta 2-receptors to G-proteins. Taken together, these actions have the following impact:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Increased beta 2-agonist effects (eg, mast cell stabilization)",
"     </li>",
"     <li>",
"      Protection from the down-regulation of beta 2-receptors that is associated with long-term beta 2-agonist administration [",
"      <a class=\"abstract\" href=\"UTD.htm?21/51/22325/abstract/19\">",
"       19",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Reversal or prevention of the uncoupling of beta 2-receptors from G proteins, which is induced by some inflammatory mediators (eg, interleukin-1 beta) [",
"      <a class=\"abstract\" href=\"UTD.htm?21/51/22325/abstract/20\">",
"       20",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In a reciprocal manner, beta 2-agonists influence the activated GR. Specifically, beta 2-agonists increase translocation of the activated GR from the cytoplasm to the nucleus, which enhances the anti-inflammatory effects of glucocorticoids [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22325/abstract/21\">",
"     21",
"    </a>",
"    ]. This has been demonstrated in the sputum macrophages of patients with asthma following administration of an inhaled glucocorticoid plus an inhaled long-acting beta 2-agonist [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22325/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     GLUCOCORTICOID SENSITIVITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some patients (usually with severe asthma) fail to respond to glucocorticoids, both inhaled and systemic. Such \"steroid resistant\" asthma may be due to reduced anti-inflammatory actions of glucocorticoids, rather than impaired absorption, increased metabolism, or poor compliance. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/42/7849?source=see_link\">",
"     \"Glucocorticoid-resistant asthma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The ratio of GR alpha (which facilitates glucocorticoid action) to GR beta (which inhibits glucocorticoid action) can be altered by changing the expression GR alpha, GR beta, or both. In glucocorticoid sensitive cells the ratio tends to be higher, whereas in glucocorticoid resistant cells the ratio tends to be lower [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22325/abstract/6\">",
"     6",
"    </a>",
"    ]. However, there is little evidence that decreases in the ratio of GR alpha to GR beta reduce steroid responsiveness because the amount of GR beta is too small to influence GR action. Other molecular mechanisms are more likely to account for glucocorticoid resistance in asthma [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22325/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Inhaled glucocorticoids are potent suppressors of inflammation in the airways. They effectively control the symptoms and signs of asthma. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The success of inhaled glucocorticoids in controlling the symptoms and signs of asthma is the net result of many favorable effects in the airways. These effects include:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Anti-inflammatory gene activation and switching off inflammatory gene expression, which combine to inhibit inflammatory cells infiltration and survival in the airways. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Suppression of inflammation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Increased expression of beta 2-receptors and enhanced coupling of beta 2-receptors to G-proteins, which combine to increase beta 2 adrenergic signaling. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Beta 2-receptor effects'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Steroid resistant asthma is most commonly due to reduced anti-inflammatory actions of glucocorticoids, rather than impaired absorption, increased metabolism, or poor compliance. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Glucocorticoid sensitivity'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/42/7849?source=see_link\">",
"       \"Glucocorticoid-resistant asthma\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22325/abstract/1\">",
"      Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids--new mechanisms for old drugs. N Engl J Med 2005; 353:1711.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22325/abstract/2\">",
"      Barnes PJ. Glucocorticosteroids: current and future directions. Br J Pharmacol 2011; 163:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22325/abstract/3\">",
"      Barnes PJ. Corticosteroid effects on cell signalling. Eur Respir J 2006; 27:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22325/abstract/4\">",
"      Clark AR. MAP kinase phosphatase 1: a novel mediator of biological effects of glucocorticoids? J Endocrinol 2003; 178:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22325/abstract/5\">",
"      Dostert A, Heinzel T. Negative glucocorticoid receptor response elements and their role in glucocorticoid action. Curr Pharm Des 2004; 10:2807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22325/abstract/6\">",
"      Lewis-Tuffin LJ, Cidlowski JA. The physiology of human glucocorticoid receptor beta (hGRbeta) and glucocorticoid resistance. Ann N Y Acad Sci 2006; 1069:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22325/abstract/7\">",
"      Barnes PJ, Adcock IM, Ito K. Histone acetylation and deacetylation: importance in inflammatory lung diseases. Eur Respir J 2005; 25:552.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22325/abstract/8\">",
"      Ito K, Barnes PJ, Adcock IM. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. Mol Cell Biol 2000; 20:6891.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22325/abstract/9\">",
"      Bergmann MW, Staples KJ, Smith SJ, et al. Glucocorticoid inhibition of granulocyte macrophage-colony-stimulating factor from T cells is independent of control by nuclear factor-kappaB and conserved lymphokine element 0. Am J Respir Cell Mol Biol 2004; 30:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22325/abstract/10\">",
"      Brook M, Tchen CR, Santalucia T, et al. Posttranslational regulation of tristetraprolin subcellular localization and protein stability by p38 mitogen-activated protein kinase and extracellular signal-regulated kinase pathways. Mol Cell Biol 2006; 26:2408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22325/abstract/11\">",
"      Hart L, Lim S, Adcock I, et al. Effects of inhaled corticosteroid therapy on expression and DNA-binding activity of nuclear factor kappaB in asthma. Am J Respir Crit Care Med 2000; 161:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22325/abstract/12\">",
"      Gibson PG, Saltos N, Fakes K. Acute anti-inflammatory effects of inhaled budesonide in asthma: a randomized controlled trial. Am J Respir Crit Care Med 2001; 163:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22325/abstract/13\">",
"      Ketchell RI, Jensen MW, Lumley P, et al. Rapid effect of inhaled fluticasone propionate on airway responsiveness to adenosine 5'-monophosphate in mild asthma. J Allergy Clin Immunol 2002; 110:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22325/abstract/14\">",
"      Juniper EF, Kline PA, Vanzieleghem MA, et al. Long-term effects of budesonide on airway responsiveness and clinical asthma severity in inhaled steroid-dependent asthmatics. Eur Respir J 1990; 3:1122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22325/abstract/15\">",
"      Barnes PJ. Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids. Eur Respir J 2002; 19:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22325/abstract/16\">",
"      Nino G, Hu A, Grunstein JS, Grunstein MM. Mechanism of glucocorticoid protection of airway smooth muscle from proasthmatic effects of long-acting beta2-adrenoceptor agonist exposure. J Allergy Clin Immunol 2010; 125:1020.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22325/abstract/17\">",
"      Mak JC, Nishikawa M, Barnes PJ. Glucocorticosteroids increase beta 2-adrenergic receptor transcription in human lung. Am J Physiol 1995; 268:L41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22325/abstract/18\">",
"      Baraniuk JN, Ali M, Brody D, et al. Glucocorticoids induce beta2-adrenergic receptor function in human nasal mucosa. Am J Respir Crit Care Med 1997; 155:704.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22325/abstract/19\">",
"      Mak JC, Nishikawa M, Shirasaki H, et al. Protective effects of a glucocorticoid on downregulation of pulmonary beta 2-adrenergic receptors in vivo. J Clin Invest 1995; 96:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22325/abstract/20\">",
"      Mak JC, Chuang TT, Harris CA, Barnes PJ. Increased expression of G protein-coupled receptor kinases in cystic fibrosis lung. Eur J Pharmacol 2002; 436:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22325/abstract/21\">",
"      Roth M, Johnson PR, R&uuml;diger JJ, et al. Interaction between glucocorticoids and beta2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling. Lancet 2002; 360:1293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22325/abstract/22\">",
"      Usmani OS, Ito K, Maneechotesuwan K, et al. Glucocorticoid receptor nuclear translocation in airway cells after inhaled combination therapy. Am J Respir Crit Care Med 2005; 172:704.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22325/abstract/23\">",
"      Barnes PJ, Adcock IM. Glucocorticoid resistance in inflammatory diseases. Lancet 2009; 373:1905.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 548 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-203.80.222.8-62FEFCC119-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_51_22325=[""].join("\n");
var outline_f21_51_22325=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H8\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      SUPPRESSION OF INFLAMMATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Anti-inflammatory gene activation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Switching off inflammatory genes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Inflammatory cell inhibition",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      BETA 2-RECEPTOR EFFECTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      GLUCOCORTICOID SENSITIVITY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/548\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/548|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?5/28/5573\" title=\"figure 1\">",
"      Glucocorticoid cellular effects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?11/42/11940\" title=\"figure 2\">",
"      Glucocorticoid effects on gene expression",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?12/30/12773\" title=\"figure 3\">",
"      Glucocorticoid gene suppression",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/61/31703?source=related_link\">",
"      Determinants of glucocorticoid dosing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/42/7849?source=related_link\">",
"      Glucocorticoid-resistant asthma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/42/23208?source=related_link\">",
"      Pharmacologic use of glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/46/18154?source=related_link\">",
"      Treatment of intermittent and mild persistent asthma in adolescents and adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/7/26745?source=related_link\">",
"      Treatment of moderate persistent asthma in adolescents and adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_51_22326="Perioral dermatitis in a male";
var content_f21_51_22326=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F73223&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F73223&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 475px\">",
"   <div class=\"ttl\">",
"    Perioral dermatitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 455px; height: 583px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple erythematous papules are present around the mouth.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_51_22326=[""].join("\n");
var outline_f21_51_22326=null;
var title_f21_51_22327="Initial assessment and stabilization of children with respiratory or circulatory compromise";
var content_f21_51_22327=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Initial assessment and stabilization of children with respiratory or circulatory compromise",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/51/22327/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/51/22327/contributors\">",
"     Susan Fuchs, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/51/22327/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/51/22327/contributors\">",
"     Susan B Torrey, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/51/22327/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/51/22327/contributors\">",
"     James F Wiley, II, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/51/22327/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 17, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial evaluation of critically ill children must quickly identify those with respiratory or circulatory compromise. Early recognition and treatment of a patient with deficiencies in oxygenation, ventilation, or perfusion frequently prevents deterioration to respiratory or cardiac arrest. Outcomes for children who develop cardiopulmonary arrest are poor [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22327/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will review the clinical features that rapidly identify children with respiratory failure or circulatory compromise. Priorities for initial stabilization are presented.",
"   </p>",
"   <p>",
"    Airway management techniques, including rapid sequence intubation (RSI), are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/22/29030?source=see_link\">",
"     \"Basic airway management in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/48/29450?source=see_link\">",
"     \"Emergent endotracheal intubation in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/29/24026?source=see_link\">",
"     \"Rapid sequence intubation (RSI) in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    More detailed discussions of assessment of circulation and the definition and treatment of shock are also discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/17/28948?source=see_link\">",
"     \"Assessment of perfusion in pediatric resuscitation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/57/42901?source=see_link\">",
"     \"Physiology and classification of shock in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most children with respiratory or cardiovascular compromise can be easily recognized during a rapid initial assessment. Obvious examples include children with respiratory conditions such as severe asthma exacerbations, or inadequate perfusion, such as hypovolemic shock. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/17/28948?source=see_link\">",
"     \"Assessment of perfusion in pediatric resuscitation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Children with subtle features of physiologic compromise can also be identified with a systematic evaluation of key clinical findings. Frequent reevaluation and close monitoring are essential to quickly recognize those whose conditions are deteriorating.",
"   </p>",
"   <p>",
"    Throughout the evaluation, interventions to provide oxygen, support ventilation, and improve perfusion should be promptly administered as indicated. A detailed physical examination and ancillary studies, such as pulse oximetry and end-tidal CO2 (ETCO2) monitoring, will determine the need for more aggressive supportive care and guide treatment of the underlying condition.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Pediatric assessment triangle",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pediatric assessment triangle (PAT) is a rapid assessment that relies on three observations to quickly identify a child with respiratory or circulatory compromise, or both, who requires immediate supportive care [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22327/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Appearance",
"     </li>",
"     <li>",
"      Breathing",
"     </li>",
"     <li>",
"      Circulatory status",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition to recognizing children who require stabilization with respiratory or cardiovascular interventions, the PAT also identifies most children with a serious illness who should receive prompt evaluation. A child in respiratory failure may have abnormal work of breathing with either abnormal appearance or circulation, while a patient with abnormalities in all three of the components of the PAT is likely in impending cardiopulmonary arrest. In comparison, an infant with an abnormal appearance alone may be physiologically stable, but have a life-threatening infection such as meningitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Appearance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Young children in an unfamiliar environment can be agitated, crying, or resist examination. Such patients must be distinguished from children who are restless or anxious as the result of hypoxia, or somnolent from hypercarbia, severe hypoxia, or shock. The following characteristics of a child's appearance (the \"TICLS\" mnemonic) help the clinician distinguish between a developmentally appropriate response and signs of serious illness [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22327/abstract/4\">",
"     4",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Tone &ndash; What is the infant's muscle tone? Vigorous movement and normal muscle tone are reassuring. In comparison, children who are seriously ill may have decreased muscle tone or appear limp and weak.",
"     </li>",
"     <li>",
"      Interactiveness &ndash; Is the child playful and interactive, or indifferent to distractions in the environment? A child who will reach for a toy or exhibit developmentally appropriate stranger anxiety is less worrisome than one who does not respond to a caregiver or appropriately resist examination.",
"     </li>",
"     <li>",
"      Consolability &ndash; Can the infant be consoled or distracted by a parent or caregiver? Crying may be a nonspecific symptom that indicates anxiety or hunger, rather than severe discomfort.",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Look/gaze",
"      </span>",
"      &ndash; Does the infant or child focus on people or objects in the environment, or is the gaze unfocused? An unresponsive stare suggests an altered mental status.",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Speech/cry",
"      </span>",
"      &ndash; Is the crying loud and strong, or weak [",
"      <a class=\"abstract\" href=\"UTD.htm?21/51/22327/abstract/4,5\">",
"       4,5",
"      </a>",
"      ]? Similar to decreased muscle tone, a weak cry is an important indication of serious illness. In addition, a hoarse or muffled voice suggests upper airway obstruction.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A child who is alert, easily consolable when crying, has good muscle tone, and responds to a caregiver is unlikely to be critically ill. On the other hand, the clinician should be very concerned about an infant who is limp, not interactive, listless, and has a weak cry.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Work of breathing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with deficiencies in oxygenation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    ventilation may have some evidence of respiratory compromise, as indicated by increased work of breathing. Decreased work of breathing may be noted as the patient becomes fatigued and progresses toward respiratory failure and respiratory arrest.",
"   </p>",
"   <p>",
"    Assessment of airway sounds, the child's position of comfort, and use of accessory muscles provides information regarding the patient's work of breathing.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Airway sounds &ndash; Abnormal airway sounds that can be heard without a stethoscope are often an indication of respiratory distress. These include stridor, snoring, grunting, and wheezing.",
"     </li>",
"     <li>",
"      Positioning &ndash; To maximize airway opening when there is obstruction, a child may assume the \"sniffing position\" (neck flexed, head mildly extended) to align the airway axes and improve airflow. For older children, the tripod position, in which the child is sitting up and leaning forward on outstretched hands, may be preferred.",
"     </li>",
"     <li>",
"      Accessory muscle use &ndash; Patients with inadequate oxygenation or ventilation often use accessory muscles (such as supraclavicular, intercostal,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      substernal groups) to increase tidal volume, thereby improving minute ventilation. Retractions result from the use of accessory muscles. They can be supraclavicular, intercostal,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      substernal. Severe retractions of more than one muscle group indicate significant hypoxia.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Head bobbing (extension of the head on inhalation and forward movement on exhalation) and nasal flaring (opening of the nostrils to allow the passage of more air) are additional indicators of accessory muscle use and respiratory distress [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22327/abstract/5,6\">",
"     5,6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A child who has abnormal breathing sounds, is in a position to maximize airflow, and is using accessory muscles is in respiratory distress.",
"   </p>",
"   <p>",
"    These features are described in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/61/7130?source=see_link&amp;anchor=H23#H23\">",
"     \"Emergent evaluation of acute respiratory compromise in children\", section on 'Physical examination'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Circulation to the skin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pallor or cyanosis is a worrisome finding that may indicate hypoxemia or inadequate perfusion to the skin. Poor capillary refill or cool skin also occurs with poor perfusion. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/17/28948?source=see_link&amp;anchor=H4#H4\">",
"     \"Assessment of perfusion in pediatric resuscitation\", section on 'Skin examination and capillary refill'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, cool environmental temperatures can cause peripheral vasoconstriction in healthy young infants, resulting in a mottled appearance to the skin in an infant who has normal circulation. Similarly, acrocyanosis (as the result of vasomotor instability) may be a normal finding in infants less than two months of age [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22327/abstract/5,6\">",
"     5,6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Following the rapid initial assessment (PAT) and initiation of appropriate supportive care, a thorough physical examination should be performed. This information may identify the underlying condition and guide specific treatment. In addition, it establishes a baseline from which changes in the child's condition can be recognized and supportive care and specific treatment modified. As an example, the condition of a child who was initially in severe respiratory distress with an anxious appearance and now has decreased work of breathing and lethargy has deteriorated from respiratory distress to respiratory failure. The patient may now require assisted ventilation, as well as supplemental oxygen.",
"   </p>",
"   <p>",
"    Vital signs should be obtained, particularly respiratory rate, heart rate, blood pressure, and pulse oximetry. Weight in kilograms should also be recorded whenever possible.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Estimation of weight",
"    </span>",
"    &nbsp;&mdash;&nbsp;An accurate weight may not be available for a child who requires weight-based interventions such as medications and fluid resuscitation. Caretaker and health care provider weight estimates can be inaccurate [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22327/abstract/7,8\">",
"     7,8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Methods that are used to estimate weight include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Age-based formulas, such as weight (kg) = 2(age in years + 4)",
"     </li>",
"     <li>",
"      Length measurements, such as the Broselow tape",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These methods often underestimate the child's actual weight [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22327/abstract/9-14\">",
"     9-14",
"    </a>",
"    ]. Nevertheless, since most resuscitation drugs have a volume of distribution associated with lean weight, they provide reasonable estimates when weights cannot be measured [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22327/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Key assessments",
"    </span>",
"    &nbsp;&mdash;&nbsp;Essential aspects of the physical examination include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Respiratory evaluation &ndash; The respiratory rate and pattern of respiration should be noted. Auscultatory findings provide essential information regarding tidal volume and localized disease processes (upper versus lower airway sounds, symmetry of breath sounds, focally abnormal lower airway findings). A detailed discussion of the physical examination for children with respiratory distress can be found separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/61/7130?source=see_link&amp;anchor=H23#H23\">",
"       \"Emergent evaluation of acute respiratory compromise in children\", section on 'Physical examination'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Cardiac examination &ndash; Heart rate, blood pressure, and evaluation of end organ perfusion provide a more precise evaluation of the child's circulatory status. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/17/28948?source=see_link\">",
"       \"Assessment of perfusion in pediatric resuscitation\"",
"      </a>",
"      .) In addition, abnormal heart sounds (such as a gallop rhythm or a murmur) may indicate a cardiac etiology, such as heart failure, for the child's condition.",
"     </li>",
"     <li>",
"      Neurologic assessment &ndash; Level of consciousness provides an important indication of brain perfusion. It can be quickly categorized using the AVPU scale, where A is alert, V responds to verbal commands, P responds to painful stimuli, and U is unresponsive. Abnormal level of consciousness may result from a non-neurologic cause (such as hypoxia or hypovolemic shock) or from a primary neurologic disorder. Focal findings consistent with a neurologic process include abnormalities in pupillary light response, extraocular movements, or motor activity.",
"     </li>",
"     <li>",
"      Skin &ndash; Examination of the skin may provide information regarding the patient's circulatory status, as well as clues to a specific underlying condition. For instance, petechiae or purpura indicates an infectious process such as meningococcemia, while urticaria suggests anaphylaxis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Ancillary studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;The PAT and physical examination identify many of the critically ill children who require airway support. Pulse oximetry provides rapid quantitative information regarding oxygenation. The addition of noninvasive bedside technology to measure end-tidal CO2 allows the clinician to quickly identify patients with inadequate ventilation as well.",
"   </p>",
"   <p>",
"    Noninvasive measures of oxygenation and ventilation have limitations. Therefore, arterial samples may be required to accurately assess oxygenation and ventilation for some patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Pulse oximetry",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulse oximetry is a noninvasive technique in which a sensor is placed on the skin (usually a digit or ear lobe). The sensor then measures the absorption of light by oxygenated and deoxygenated hemoglobin to determine the percent of hemoglobin that is saturated with oxygen. The spectrophotometric principles of pulse oximetry are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/32/9736?source=see_link&amp;anchor=H3#H3\">",
"     \"Pulse oximetry\", section on 'Principles'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pulse oximetry should be monitored continuously for measurements below 94 percent. Within the range of PaO2 that represents clinically significant hypoxemia, small changes in the level of saturated hemoglobin reflect much larger decreases in PaO2 (",
"    <a class=\"graphic graphic_figure graphicRef81216 \" href=\"UTD.htm?2/26/2479\">",
"     figure 1",
"    </a>",
"    ). As an example, a SpO2 of 98 percent correlates with a PaO2 of approximately 100 mmHg, 95 percent with 80 mmHg, and 90 percent with 60 mmHg; the last value is a level that represents clinically significant hypoxia.",
"   </p>",
"   <p>",
"    Technical difficulties such as improper placement of the sensor or motion can create artifacts that make the oximeter reading unreliable. In addition, low perfusion states, the presence of abnormal hemoglobin (such as carboxyhemoglobin or methemoglobin), and anemia can also result in inaccurate pulse oximetry readings. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/32/9736?source=see_link&amp;anchor=H6#H6\">",
"     \"Pulse oximetry\", section on 'Sources of artifact'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/32/9736?source=see_link&amp;anchor=H7#H7\">",
"     \"Pulse oximetry\", section on 'Patient-related errors'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/61/29656?source=see_link&amp;anchor=H15#H15\">",
"     \"Oxygen monitoring and therapy in the newborn\", section on 'Pulse oximetry'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     End-tidal carbon dioxide measurement",
"    </span>",
"    &nbsp;&mdash;&nbsp;Capnographic devices measure end-tidal CO2 (ETCO2) and display fluctuations in levels over the ventilatory cycle as a waveform [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22327/abstract/16\">",
"     16",
"    </a>",
"    ]. They are routinely used for intubated patients to confirm endotracheal tube placement and monitor ventilation. With a sidestream sampling technique, ETCO2 measurement can also be used to assess ventilation in non-intubated patients [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22327/abstract/17-19\">",
"     17-19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    ETCO2 measurement should be used, when available, to evaluate ventilation for any patient who may be at risk to develop respiratory failure. It is particularly valuable for those receiving supplemental oxygen who can experience a significant decrease in ventilation without a noticeable change in oxygen saturation, such as patients who are undergoing sedation [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22327/abstract/16,20\">",
"     16,20",
"    </a>",
"    ]. ETCO2 monitoring is reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/18/44328?source=see_link\">",
"     \"Carbon dioxide monitoring (capnography)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Transcutaneous CO2 measurement",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transcutaneous measurement of CO2 has been used primarily for neonates and in the operating room for infants and children up to 16 years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22327/abstract/17,21\">",
"     17,21",
"    </a>",
"    ]. With this method, a heated electrode, placed on the skin, measures changes in pH as a result of CO2 that has diffused from capillary beds to the skin. CO2 levels are extrapolated from this measurement.",
"   </p>",
"   <p>",
"    Similar to ETCO2, transcutaneous CO2 measurement (TCO2) can be useful to correlate clinical assessment with ventilatory status. In one prospective study, an excellent correlation between TCO2 measurements and PaCO2 values from simultaneously obtained arterial samples was noted [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22327/abstract/17\">",
"     17",
"    </a>",
"    ]. However, TCO2 can be difficult to use in emergency situations because it requires time to calibrate. In addition, transcutaneous CO2 measurement is unreliable in shock, hypothermia, and for patients who are receiving vasoconstrictor medications [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22327/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Arterial blood gas/venous blood gas",
"    </span>",
"    &nbsp;&mdash;&nbsp;Accurate information regarding a critically ill patient's oxygenation, ventilation, and acid base status is an essential determinant of optimum management. Sampling of arterial blood should be performed in the following circumstances:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      To assess ventilation when ETCO2 or TCO2 measurements are not available",
"     </li>",
"     <li>",
"      To correlate with trends in noninvasive monitoring",
"     </li>",
"     <li>",
"      To measure PaO2 and PaCO2 when noninvasive measurements may be inaccurate",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    An arterial sample that is handled properly provides the most accurate information regarding a patient's oxygenation, ventilation, and acid base status. The technique for performing an arterial puncture and specimen handling are discussed separately, as is the interpretation of blood gas results. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/61/2009?source=see_link\">",
"     \"Arterial puncture and cannulation in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/8/33925?source=see_link\">",
"     \"Oxygenation and mechanisms of hypoxemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Venous pH generally correlates well with arterial pH. However, the correlation between venous and arterial PaCO2 and PaO2 is not sufficient to provide an accurate assessment of ventilation and oxygenation in critically ill patients [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22327/abstract/22,23\">",
"     22,23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     INITIAL STABILIZATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children who have abnormalities identified using the pediatric assessment triangle (PAT) are critically ill and require immediate intervention. Information from the physical examination",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    ancillary studies may also provide indications for respiratory or circulatory support.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Supplemental oxygen",
"    </span>",
"    &nbsp;&mdash;&nbsp;Supplemental oxygen should be considered for any child who appears seriously ill, as determined by the PAT (appearance, breathing, circulation). As a general rule, patients with two or more abnormalities in the PAT require oxygen therapy. In addition, most patients with an oxygen saturation &le;94 percent should receive supplemental oxygen.",
"   </p>",
"   <p>",
"    For children who are breathing spontaneously, low concentrations of oxygen can be delivered by blow-by, nasal cannula, or a simple face mask. The choice of delivery system depends on factors such as the dose of oxygen required and how well the child accepts the device. A nonrebreather mask with reservoir is required to deliver higher concentrations. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/24/27014?source=see_link\">",
"     \"Continuous oxygen delivery systems for infants, children, and adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pulse oximetry should be monitored for patients who are receiving supplemental oxygen.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Assisted ventilation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with apnea or bradypnea require assisted ventilation. Others who need ventilatory support may only be identified by CO2 measurement, either from an arterial blood gas or with ETCO2 or TCO2 measurement. As an example, a child with status epilepticus who is breathing spontaneously and receiving supplemental oxygen may have an elevated ETCO2 or TCO2 with an oxygen saturation of 100 percent. Similarly, an infant with a respiratory rate of 70 and a TCO2 measurement of 50 has significant respiratory compromise despite a pulse oximetry reading of 98 percent.",
"   </p>",
"   <p>",
"    Assisted ventilation should initially be provided with bag-mask ventilation (BMV). Endotracheal intubation may be necessary for those who are not expected to improve quickly. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/22/29030?source=see_link&amp;anchor=H9#H9\">",
"     \"Basic airway management in children\", section on 'Ventilation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/48/29450?source=see_link\">",
"     \"Emergent endotracheal intubation in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As a note of caution, children who resist BMV should be given supplemental oxygen and re-evaluated. Rapid sequence intubation (RSI) should be considered for those who continue to have poor ventilation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/29/24026?source=see_link\">",
"     \"Rapid sequence intubation (RSI) in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Circulatory support",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with inadequate perfusion as indicated by decreased mental status, poor skin perfusion,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    abnormal vital signs are in shock. Vascular access should be established, and they should receive fluid resuscitation. Vascular access and the initial management of shock are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/55/8057?source=see_link\">",
"     \"Vascular (venous) access for pediatric resuscitation and other pediatric emergencies\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/51/40761?source=see_link\">",
"     \"Intraosseous infusion\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/8/26762?source=see_link\">",
"     \"Initial management of shock in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children who are critically ill require frequent assessment and continuous monitoring of vital signs, particularly heart rate and pulse oximetry. This is essential to evaluate the effectiveness of interventions and to identify clinical deterioration.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rapid identification and stabilization of critically ill children with respiratory or circulatory compromise are essential components of evaluation and management. Critically ill children who require immediate stabilization of respiratory and circulatory function can generally be identified through the following evaluation. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Evaluation'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pediatric assessment triangle (PAT) &ndash; The three components of the PAT are appearance, breathing, and circulation. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Pediatric assessment triangle'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      <strong>",
"       Appearance",
"      </strong>",
"      &ndash; Children who require prompt supportive care may have abnormal tone, decreased interactiveness, poor color, abnormal stare, or a weak cry.",
"     </li>",
"     <li>",
"      <strong>",
"       Breathing",
"      </strong>",
"      &ndash; Abnormal airway sounds, a position of comfort that maximizes airway opening, and use of accessory muscles indicate increased work of breathing.",
"     </li>",
"     <li>",
"      <strong>",
"       Circulation to the skin",
"      </strong>",
"      &ndash; Pallor or cyanosis may occur with decreased perfusion as well as with hypoxemia. Poor capillary refill or cool skin also indicates poor perfusion.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A thorough physical examination, with attention to assessment of respiratory, cardiovascular, neurologic functions, and skin provides additional information to guide assessment and treatment. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Weight can be estimated using an age-based formula or length measurement when an actual weight is not available. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Estimation of weight'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pulse oximetry and end-tidal or transcutaneous CO2 measurement often provide a rapid noninvasive evaluation of oxygenation and ventilation. However, an arterial sample provides the most accurate measurement of PaO2, PaCO2, and pH. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Ancillary studies'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The initial stabilization of the critically ill child must occur concurrently with evaluation and treatment of the underlying condition. We suggest the following approach (see",
"    <a class=\"local\" href=\"#H15\">",
"     'Initial stabilization'",
"    </a>",
"    above):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Most children with two or more abnormalities in the PAT or an oxygen saturation &le;94 percent should receive oxygen therapy.",
"     </li>",
"     <li>",
"      Oxygen should be provided at the highest concentration available through whatever device the child tolerates. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/24/27014?source=see_link\">",
"       \"Continuous oxygen delivery systems for infants, children, and adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Children with respiratory failure or impending respiratory arrest (as suggested by apnea, bradypnea, or an irregular respiratory pattern) should initially receive bag-mask ventilation. Further airway management, including endotracheal intubation, may be required. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/22/29030?source=see_link\">",
"       \"Basic airway management in children\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/48/29450?source=see_link\">",
"       \"Emergent endotracheal intubation in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Critically ill children should be closely monitored with frequent vital signs and pulse oximetry to evaluate the effectiveness of interventions and to identify clinical deterioration.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22327/abstract/1\">",
"      Donoghue AJ, Nadkarni V, Berg RA, et al. Out-of-hospital pediatric cardiac arrest: an epidemiologic review and assessment of current knowledge. Ann Emerg Med 2005; 46:512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22327/abstract/2\">",
"      Ludwig S, Kettrick RG, Parker M. Pediatric cardiopulmonary resuscitation. A review of 130 cases. Clin Pediatr (Phila) 1984; 23:71.",
"     </a>",
"    </li>",
"    <li>",
"     Pediatric Advanced Life Support Provider Manual. Hazinski MF, Samson RA, Schexnayder SM (Eds). American Heart Association, Dallas, 2012.",
"    </li>",
"    <li>",
"     American Academy of Pediatrics, American College of Emergency Physicians. APLS: The Pediatric Emergency Medicine Resource, 5th, Fuchs S, Yamamoto L.  (Eds), Jones and Bartlett Learning, Sudbury 2012.",
"    </li>",
"    <li>",
"     Gausche-Hill M, Henderson DP, Goodrich SM, et al. Assessment. In: Pediatric Airway Management for the Prehospital Professional, Gausche-Hill M, Henderson DP, Goodrich SM, et al (Eds), Jones and Bartlett, Sudbury 2004. p.13.",
"    </li>",
"    <li>",
"     American Academy of Pediatrics. Pediatric assessment. In: Pediatric Education for Prehospital Professionals, 2nd, Dieckman RA (Ed), Jones and Bartlett, Sudbury 2006. p.3.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22327/abstract/7\">",
"      Leffler S, Hayes M. Analysis of parental estimates of children's weights in the ED. Ann Emerg Med 1997; 30:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22327/abstract/8\">",
"      Harris M, Patterson J, Morse J. Doctors, nurses, and parents are equally poor at estimating pediatric weights. Pediatr Emerg Care 1999; 15:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22327/abstract/9\">",
"      Argall JA, Wright N, Mackway-Jones K, Jackson R. A comparison of two commonly used methods of weight estimation. Arch Dis Child 2003; 88:789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22327/abstract/10\">",
"      Nguyen K, Krieser D, Kerr D, et al. Failed validation of the Argall weight formula for estimating children's weight in an Australian emergency department. Acad Emerg Med 2007; 14:486.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22327/abstract/11\">",
"      Luscombe M, Owens B. Weight estimation in resuscitation: is the current formula still valid? Arch Dis Child 2007; 92:412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22327/abstract/12\">",
"      Nieman CT, Manacci CF, Super DM, et al. Use of the Broselow tape may result in the underresuscitation of children. Acad Emerg Med 2006; 13:1011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22327/abstract/13\">",
"      Jang HY, Shin SD, Kwak YH. Can the Broselow tape be used to estimate weight and endotracheal tube size in Korean children? Acad Emerg Med 2007; 14:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22327/abstract/14\">",
"      DuBois D, Baldwin S, King WD. Accuracy of weight estimation methods for children. Pediatr Emerg Care 2007; 23:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22327/abstract/15\">",
"      Dieckmann RA. The dilemma of paediatric drug dosing and equipment sizing in the era of patient safety. Emerg Med Australas 2007; 19:490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22327/abstract/16\">",
"      Mace, SE. End-tidal CO2 monitoring: Noninvasive respiratory monitoring for the child in the ED. Pediatric Emergency Medicine Reports 2006; 11:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22327/abstract/17\">",
"      Berkenbosch JW, Lam J, Burd RS, Tobias JD. Noninvasive monitoring of carbon dioxide during mechanical ventilation in older children: end-tidal versus transcutaneous techniques. Anesth Analg 2001; 92:1427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22327/abstract/18\">",
"      Abramo TJ, Wiebe RA, Scott SM, et al. Noninvasive capnometry in a pediatric population with respiratory emergencies. Pediatr Emerg Care 1996; 12:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22327/abstract/19\">",
"      Tobias JD, Meyer DJ. Noninvasive monitoring of carbon dioxide during respiratory failure in toddlers and infants: end-tidal versus transcutaneous carbon dioxide. Anesth Analg 1997; 85:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22327/abstract/20\">",
"      Burton JH, Harrah JD, Germann CA, Dillon DC. Does end-tidal carbon dioxide monitoring detect respiratory events prior to current sedation monitoring practices? Acad Emerg Med 2006; 13:500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22327/abstract/21\">",
"      DeNicola LK, Kissoon N, Abram HS Jr, et al. Noninvasive monitoring in the pediatric intensive care unit. Pediatr Clin North Am 2001; 48:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22327/abstract/22\">",
"      Gennis PR, Skovron ML, Aronson ST, Gallagher EJ. The usefulness of peripheral venous blood in estimating acid-base status in acutely ill patients. Ann Emerg Med 1985; 14:845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22327/abstract/23\">",
"      Kirubakaran C, Gnananayagam JE, Sundaravalli EK. Comparison of blood gas values in arterial and venous blood. Indian J Pediatr 2003; 70:781.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6393 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-197.136.42.3-1591A33FAF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_51_22327=[""].join("\n");
var outline_f21_51_22327=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H20\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Pediatric assessment triangle",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Appearance",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Work of breathing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Circulation to the skin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Estimation of weight",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Key assessments",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Ancillary studies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Pulse oximetry",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - End-tidal carbon dioxide measurement",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Transcutaneous CO2 measurement",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Arterial blood gas/venous blood gas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      INITIAL STABILIZATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Supplemental oxygen",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Assisted ventilation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Circulatory support",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Monitoring",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/6393\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6393|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?2/26/2479\" title=\"figure 1\">",
"      Hemoglobin oxygen dissociation curve",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/61/2009?source=related_link\">",
"      Arterial puncture and cannulation in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/17/28948?source=related_link\">",
"      Assessment of perfusion in pediatric resuscitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/22/29030?source=related_link\">",
"      Basic airway management in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/18/44328?source=related_link\">",
"      Carbon dioxide monitoring (capnography)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/24/27014?source=related_link\">",
"      Continuous oxygen delivery systems for infants, children, and adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/48/29450?source=related_link\">",
"      Emergent endotracheal intubation in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/61/7130?source=related_link\">",
"      Emergent evaluation of acute respiratory compromise in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/8/26762?source=related_link\">",
"      Initial management of shock in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/51/40761?source=related_link\">",
"      Intraosseous infusion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/61/29656?source=related_link\">",
"      Oxygen monitoring and therapy in the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/8/33925?source=related_link\">",
"      Oxygenation and mechanisms of hypoxemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/57/42901?source=related_link\">",
"      Physiology and classification of shock in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/32/9736?source=related_link\">",
"      Pulse oximetry",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/29/24026?source=related_link\">",
"      Rapid sequence intubation (RSI) in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/55/8057?source=related_link\">",
"      Vascular (venous) access for pediatric resuscitation and other pediatric emergencies",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_51_22328="Invasive cardiac electrophysiology studies: Bradyarrhythmias";
var content_f21_51_22328=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Invasive cardiac electrophysiology studies: Bradyarrhythmias",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/51/22328/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/51/22328/contributors\">",
"     Joseph J Germano, DO",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/51/22328/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/51/22328/contributors\">",
"     Peter J Zimetbaum, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/51/22328/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/51/22328/contributors\">",
"     Brian C Downey, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/51/22328/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 28, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies of cardiac impulse formation and conduction using intracardiac catheters have helped define the mechanisms of bradyarrhythmias [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22328/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. These invasive electrophysiology studies (EPS) have become a valuable clinical tool in the evaluation and management of cardiac dysrhythmias.",
"   </p>",
"   <p>",
"    Significant bradyarrhythmias can be divided into two major categories, depending on the anatomic site of origin:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Sinus node (SN) dysfunction",
"     </li>",
"     <li>",
"      Atrioventricular (AV) conduction disorders",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This topic will review the role of invasive EPS in the diagnosis and treatment of patients with bradyarrhythmias, particularly its role in determining the need for a permanent pacemaker. An overview of cardiac electrophysiology and its role in the management of tachyarrhythmias are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/2/12326?source=see_link\">",
"     \"Overview of invasive cardiac electrophysiology studies\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/1/3097?source=see_link\">",
"     \"Invasive cardiac electrophysiology studies: Tachyarrhythmias\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     GENERAL APPROACH",
"    </span>",
"    &nbsp;&mdash;&nbsp;EPS should be used as an adjunct to clinical history, physical examination, electrocardiography, and other noninvasive methods in the evaluation of bradyarrhythmias. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/54/9064?source=see_link\">",
"     \"Diagnosis and evaluation of the sick sinus syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When determining the need for pacemaker therapy, attempts should always be made to correlate symptoms (presyncope, syncope, hemodynamic compromise) with bradycardia",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    pauses. Invasive studies are valuable when symptoms cannot be clearly correlated and when significant bradyarrhythmias are suspected but previously undocumented.",
"   </p>",
"   <p>",
"    General indications for invasive EPS have been described by the American College of Cardiology and the American Heart Association Task Force on Practice Guidelines, in conjunction with the North American Society of Pacing and Electrophysiology [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22328/abstract/5\">",
"     5",
"    </a>",
"    ]. Performance of these procedures requires specialized training and an awareness of the indications, contraindications, and potential complications [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22328/abstract/6-8\">",
"     6-8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Absolute contraindications to EPS include [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22328/abstract/6\">",
"     6",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Unstable angina",
"     </li>",
"     <li>",
"      Bacteremia or septicemia",
"     </li>",
"     <li>",
"      Acute decompensated congestive heart failure not caused by the arrhythmia",
"     </li>",
"     <li>",
"      Major bleeding diathesis",
"     </li>",
"     <li>",
"      Acute lower extremity venous thrombosis if femoral vein cannulation is desired",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     SINUS NODE DYSFUNCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sinus node (SN) dysfunction can be classified into disorders of automaticity, conduction, or both. Abnormal automaticity, or sinus arrest, refers to a failure of sinus impulse generation. Abnormal conduction, or sinoatrial delay or block, is a failure of impulse transmission. In such cases, the sinus impulse is generated normally but it is abnormally conducted to atrial tissue.",
"   </p>",
"   <p>",
"    The following discussion will focus on the invasive evaluation of SN function. The etiology, diagnosis, and clinical manifestations of SN dysfunction are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/31/22008?source=see_link\">",
"     \"Manifestations and causes of the sick sinus syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Indirect determination of sinoatrial conduction time",
"    </span>",
"    &nbsp;&mdash;&nbsp;The usual method of calculating sinoatrial conduction time (SACT) is an indirect measure. This approach involves the placement of a catheter in the superior aspect of the right atrium approximating the main intrinsic pacemaker site of the SN. Progressively premature atrial extrastimuli (A2) are introduced by way of that catheter after every eighth to tenth beat of either a stable sinus rhythm (Strauss method) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22328/abstract/9\">",
"     9",
"    </a>",
"    ], or atrial pacing (Narula method) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22328/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The interval between each of the normal sinus beats or the stable sequence of paced beats is referred to as the A1-A1 interval (",
"    <a class=\"graphic graphic_figure graphicRef71074 \" href=\"UTD.htm?20/43/21180\">",
"     figure 1",
"    </a>",
"    ). The first spontaneous sinus beat that occurs after termination of the pacing sequence (the series of A1's followed by a single A2) is referred to as A3. The interval between the final paced impulse (A2) and the first spontaneous beat (A3) is referred to as the return interval (A2-A3). A second return cycle length (A3-A4), or secondary pause, is often measured and supplies further evidence of SN dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22328/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    To calculate the SACT using this method, the atrial extrastimulus must enter and depolarize SN tissue, thus restarting the next sinus interval from that time point, referred to as \"resetting\" of the SN. As A2 impulses are introduced progressively closer to the final A1, the \"zone of resetting\" is defined as the range of A1-A2 intervals where the A2-A3 exceeds the A1-A1, but the sum of A1-A2 and A2-A3 is less than the twice the A1-A1 (ie, less than compensatory) (",
"    <a class=\"graphic graphic_figure graphicRef71074 \" href=\"UTD.htm?20/43/21180\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The A1-A1 interval represents the time required to generate a sinus impulse (SN automaticity). Because it is measured at the same point a fixed distance from impulse generation, conduction time does not contribute to A1-A1. Because A2 resets the SN, the return cycle length (A2-A3) includes both the time for the generation of the next sinus beat (SN automaticity) and for conduction of the impulse into and out of SN tissue. Thus, the difference between the A2-A3 and the A1-A1 is an estimate of the total time it takes to enter and exit the SN tissue. This number represents twice the SACT [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22328/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    SACT = [(A2-A3) &ndash; (A1-A1)]",
"    <span class=\"nowrap\">",
"     /",
"    </span>",
"    2",
"   </p>",
"   <p>",
"    Normal SACT times generally range from 40 to 150 milliseconds, depending upon the laboratory [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22328/abstract/12,13\">",
"     12,13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Limitations of SACT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The assumption that entrance into and exit out of the SN takes the same amount of time is not necessarily valid. In addition, distance of the stimulation site from the SN is another source of error. The farther the site is from the SN, the greater the potential for overestimation of the SACT due to conduction delays in both atrial and perinodal tissues. Increased pacing rates and progressive prematurity of A2 can introduce local delay due to encroachment on refractoriness. Other common limitations include reproducibility of results, sinus arrhythmia, shift in intrinsic pacemaker site, depression of automaticity, and sinus entrance block [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22328/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Direct recording of the sinoatrial conduction time (sinus node electrogram)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Due to the limitations of indirect methods in assessing the SACT, techniques for direct recording of the sinus electrogram (EGM) were developed in animal models [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22328/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. Endocardial recordings demonstrate diastolic phase 4 activity followed by a slow upstroke culminating in a rapid atrial EGM. The directly measured SACT was defined as the interval between the local EGM and the rapid atrial deflection. Sinoatrial block occurred when the local EGM was seen in the absence of an atrial deflection [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22328/abstract/11\">",
"     11",
"    </a>",
"    ]. This method was later validated in human subjects both with and without sinus node dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22328/abstract/16-19\">",
"     16-19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Studies have shown a good correlation between indirect and direct methods of measuring SACT [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22328/abstract/16,18-20\">",
"     16,18-20",
"    </a>",
"    ]. However, SACT has been shown to be a relatively insensitive test for SN dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22328/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Sinus node recovery time",
"    </span>",
"    &nbsp;&mdash;&nbsp;The sinus node recovery time (SNRT) is another method of assessing SN function. It is performed by placing a catheter near the SN and pacing (overdrive suppression) for at least 30 seconds at a fixed cycle length starting slightly faster than the intrinsic sinus rate. This is repeated at progressively shorter cycle lengths. Pacing rates up to 200",
"    <span class=\"nowrap\">",
"     beats/minute",
"    </span>",
"    may be employed for improved sensitivity [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22328/abstract/21\">",
"     21",
"    </a>",
"    ]. It is important to wait at least one minute between pacing sequences to allow full recovery of the SN. Confirmation that the escape beat is sinus by examining P-wave morphology and atrial activation sequence is essential to exclude a shift in pacemaker site [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22328/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The maximum SNRT is the longest pause from the last pacing stimulus to the first spontaneously occurring sinus beat at any paced cycle length. As the sinus cycle length (SCL) affects the SNRT, it is often normalized or corrected:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The SNRT is normalized by dividing this value by the SCL.",
"     </li>",
"     <li>",
"      The corrected sinus node recovery time (CSNRT) is determined by subtracting the SCL from the SNRT (",
"      <a class=\"graphic graphic_waveform graphicRef58763 \" href=\"UTD.htm?11/36/11846\">",
"       waveform 1",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A total recovery time (TRT) can also be calculated, which is the time required to return to the basal sinus rate.",
"   </p>",
"   <p>",
"    Normal values have generally been estimated as follows [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22328/abstract/11\">",
"     11",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <span class=\"nowrap\">",
"       SNRT/SCL",
"      </span>",
"      &lt;150 percent",
"     </li>",
"     <li>",
"      CSNRT &lt;550 milliseconds",
"     </li>",
"     <li>",
"      TRT less than five seconds",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Limitations of SNRT",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several limitations to the use of overdrive suppression in determining SN function, which include [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22328/abstract/11\">",
"     11",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Changes in autonomic tone due to the effects of pacing",
"     </li>",
"     <li>",
"      Changes in P-wave morphology or atrial activation suggesting a pacemaker shift",
"     </li>",
"     <li>",
"      Sinoatrial entrance block",
"     </li>",
"     <li>",
"      Secondary pauses",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Pauses following SN suppression reflect not only resumption of normal SN activity (automaticity), but also sinoatrial conduction. In fact, direct SN recordings have demonstrated that the majority of these pauses are due to sinoatrial exit block rather than impaired automaticity [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22328/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     ATRIOVENTRICULAR CONDUCTION DISTURBANCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;As with sinus node (SN) dysfunction, invasive assessment of atrioventricular (AV) conduction is usually part of an evaluation of symptoms",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    electrocardiographic (ECG) abnormalities for the purpose of determining whether a permanent pacemaker is necessary. Thus, there is little utility in performing invasive electrophysiology studies (EPS) in patients with symptomatic spontaneous second and third degree AV block. Such patients have an indication of pacemaker implantation and the results of EPS would have little impact on management. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/52/27463?source=see_link\">",
"     \"Indications for permanent cardiac pacing\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, determining the site and severity of conduction disease is often possible with noninvasive methods, including surface ECG tracings, physical maneuvers and pharmacologic intervention. The etiology, classification, electrocardiographic patterns, clinical manifestations and noninvasive evaluation of AV block are covered separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/16/32007?source=see_link\">",
"     \"Etiology of atrioventricular block\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/59/15285?source=see_link\">",
"     \"Third degree (complete) atrioventricular block\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/62/998?source=see_link\">",
"     \"Second degree atrioventricular block: Mobitz type II\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/42/18087?source=see_link\">",
"     \"Second degree atrioventricular block: Mobitz type I (Wenckebach block)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/52/27463?source=see_link\">",
"     \"Indications for permanent cardiac pacing\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are, however, situations in which EPS is a useful diagnostic tool for unmasking severe AV conduction system disease:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Patients with AV block without clear symptom association",
"     </li>",
"     <li>",
"      Patients with symptoms suggestive of bradyarrhythmias, but in whom significant AV block has not been documented",
"     </li>",
"     <li>",
"      When the site of AV block cannot be determined by surface tracings",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Electrophysiologic evaluation of atrioventricular block",
"    </span>",
"    &nbsp;&mdash;&nbsp;Traditional terminology classifies AV block as first-degree, second-degree (type I and II) and third-degree. However, the clinical significance of AV block is determined not only by the severity of block or delay, but also by the anatomic location of the conduction abnormality. Invasive studies are particularly helpful in localizing the site of AV block. The typical locations of AV block include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Within the AV node",
"     </li>",
"     <li>",
"      Within the His bundle (intra-Hisian)",
"     </li>",
"     <li>",
"      Distal to the His bundle (infra-Hisian) in the His-Purkinje system",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Baseline intervals",
"    </span>",
"    &nbsp;&mdash;&nbsp;During EPS, the initial assessment of AV conduction involves measuring baseline conduction velocities. Conduction velocity is measured using a catheter approximating the His bundle to record a His bundle electrogram (EGM). These baseline intervals include the A-H interval (AV nodal conduction), H duration (intra-Hisian conduction), and H-V interval (infra-Hisian conduction) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22328/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. A review of these parameters, including normal values can be found separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/2/12326?source=see_link&amp;anchor=H5#H5\">",
"     \"Overview of invasive cardiac electrophysiology studies\", section on 'Baseline recordings'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The AV conduction system can also be evaluated by determining AV refractory periods, the response to medications (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/23/11640?source=see_link\">",
"     atropine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/34/36391?source=see_link\">",
"     procainamide",
"    </a>",
"    ), or the response to pacing maneuvers. These are discussed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Prolonged AV conduction (first-degree AV block)",
"    </span>",
"    &nbsp;&mdash;&nbsp;On surface recordings, first degree AV block is demonstrated by a long P-R interval. As there is a 1:1 relationship between the P and QRS complexes, \"block\" is an inaccurate term and this will subsequently be referred to as prolonged AV conduction.",
"   </p>",
"   <p>",
"    The majority of cases of prolonged AV conduction are due to delays in the AV node [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22328/abstract/23\">",
"     23",
"    </a>",
"    ]. Prolonged AV conduction can be due to intra-atrial conduction delays, although this is uncommon [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22328/abstract/24\">",
"     24",
"    </a>",
"    ]. Furthermore, intra- and infra-Hisian conduction are only rarely responsible for prolonged AV conduction, since intra- and infra-Hisian conduction compose only a minority of the P-R interval, so only cases of severe conduction disease will produce noticeable P-R prolongation. Thus, the most common EPS finding in patients with P-R prolongation is a long A-H interval. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/2/12326?source=see_link&amp;anchor=H7#H7\">",
"     \"Overview of invasive cardiac electrophysiology studies\", section on 'AH interval'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Second-degree AV block",
"    </span>",
"    &nbsp;&mdash;&nbsp;Type I second-degree block (Wenckebach type) almost always occurs in the AV node. During EPS, this process is most evident on a His bundle EGM. Over the beats of a Wenckebach cycle, there is typically a progressively longer A-H interval and a stable H-V interval until the final beat of the series in which there is an atrial EGM with no subsequent His or ventricular EGM.",
"   </p>",
"   <p>",
"    Less commonly, type I block is observed in the His-Purkinje system (HPS) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22328/abstract/25\">",
"     25",
"    </a>",
"    ]. Such a finding suggests severe HPS disease. With intra-Hisian block, a two component His potential (H and H') can be recorded on the His bundle EGM. In such cases, there would be progressive prolongation of the H-H' interval culminating in an atrial EGM and an H without an H' or ventricular EGM. With infra-Hisian block, the H-V interval would progressively prolong until an atrial EGM and His potential were not followed by a ventricular EGM.",
"   </p>",
"   <p>",
"    True type II second-degree block (Mobitz II) almost always, if not always, occurs in the HPS [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22328/abstract/25\">",
"     25",
"    </a>",
"    ]. As above, using the His bundle EGM, either a His potential or a split His follows the atrial EGM prior to the dropped ventricular EGM confirming the site of block.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Third-degree (complete) AV block",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complete AV block can occur in any component of the AV conduction system. Most patients with complete AV block are treated with permanent pacemakers and EPS is not generally indicated. Among patients with complete AV block, EPS may be indicated when symptoms are not present, the site of block is not apparent, or the block is potentially reversible. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/51/40759?source=see_link&amp;anchor=H4#H4\">",
"     \"Lyme carditis\", section on 'Atrioventricular conduction abnormalities'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A narrow QRS escape rhythm identical to the native QRS complex suggests block in the AV node with a His (junctional) escape rhythm. This is confirmed by demonstration of a His deflection before each QRS complex. An exception to this is a His deflection after each atrial EGM (H) and a His deflection before each QRS complex (H') demonstrating intra-Hisian block. If a His deflection is present before each QRS complex and the QRS complex is wide, and no His deflection is present after atrial electrograms, then a junctional rhythm with aberration is possible. When an escape rhythm has a wide QRS complex, but the His deflection follows each atrial EGM rather than preceding each ventricular EGM, the site of block is infra-Hisian.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Indications for EPS in patients with AV block",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted above, many patients will have a clear diagnosis and indication for pacemaker therapy based upon a simple history, physical examination and ECG (eg, those with symptomatic third-degree AV block). In addition, others can be effectively managed following further noninvasive evaluation (eg, physical maneuvers). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/46/21224?source=see_link&amp;anchor=H12#H12\">",
"     \"Vagal maneuvers\", section on 'Atrioventricular block'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, there are several settings in which EPS is an important component of management. EP studies are particularly useful in the following instances:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with Wenckebach periodicity that is more often atypical than typical [",
"      <a class=\"abstract\" href=\"UTD.htm?21/51/22328/abstract/26\">",
"       26",
"      </a>",
"      ]. Changes in the P-R interval are often subtle on surface tracings and invasive studies can differentiate AV nodal and His-Purkinje system (HPS) block. In such cases, this distinction has important implications regarding the need for pacemaker therapy.",
"     </li>",
"     <li>",
"      Second- or third-degree AV block with unclear symptom correlation. Patients with heightened vagal tone can have higher degrees of block in the AV node (eg, transient third-degree block). Such patients may not require pacemaker implantation. Careful inspection of surface tracings can suggest this diagnosis by demonstrating sinus slowing or subtle P-R prolongation during AV block. Such findings can often obviate the need for invasive studies; however, when this is not clear, invasive studies may be necessary to clarify the site of block.",
"     </li>",
"     <li>",
"      Concealed His extrasystoles (an uncommon but well-described cause of pseudo-AV block) are suspected [",
"      <a class=\"abstract\" href=\"UTD.htm?21/51/22328/abstract/27\">",
"       27",
"      </a>",
"      ]. His extrasystoles are spontaneous depolarizations from the AV junction that fail to conduct to the atrium or ventricle and are therefore not evident on surface tracings. They often penetrate the AV node in a concealed retrograde fashion and cause physiologic block of the subsequent atrial impulse (",
"      <a class=\"graphic graphic_waveform graphicRef60469 \" href=\"UTD.htm?14/58/15267\">",
"       waveform 2",
"      </a>",
"      ). The treatment of His extrasystoles does not mandate a pacemaker unless accompanied by other evidence of severe HPS disease.",
"     </li>",
"     <li>",
"      2:1 or higher degrees of AV block when the site of block cannot be determined by noninvasive evaluation. If a patient with 2:1 AV block has documented episodes of PR prolongation associated with sinus slowing, or has P-R prolongation at the time of the episode, heightened vagal tone and block in the AV node should be suspected. In contrast, a narrow QRS complex with a normal P-R interval during 2:1 block is virtually diagnostic of intra-Hisian block [",
"      <a class=\"abstract\" href=\"UTD.htm?21/51/22328/abstract/25\">",
"       25",
"      </a>",
"      ]. Infra-Hisian block is suspected when the baseline QRS complex demonstrates bundle branch block",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      fascicular block. Of note, intra- and infra-Hisian block both usually occur with acceleration of the sinus rate rather than with slowing of the sinus rate as is the case with block in the AV node.",
"      <br/>",
"      <br/>",
"      Although these ECG features can be helpful, invasive EPS is frequently needed to confirm the diagnosis, particularly if there is uncertainty regarding the need for a permanent pacemaker (",
"      <a class=\"graphic graphic_waveform graphicRef51275 \" href=\"UTD.htm?38/63/39935\">",
"       waveform 3",
"      </a>",
"      and",
"      <a class=\"graphic graphic_waveform graphicRef64837 \" href=\"UTD.htm?22/13/22741\">",
"       waveform 4",
"      </a>",
"      and",
"      <a class=\"graphic graphic_waveform graphicRef72256 \" href=\"UTD.htm?5/33/5654\">",
"       waveform 5",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Symptoms related to tachyarrhythmias are suspected. This is especially true in patients with structural heart disease",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      diminished ejection fractions.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Findings suggestive of high risk",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with extensive conduction disturbances in the His-Purkinje system (HPS) often progress to higher grades of AV block [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22328/abstract/28-33\">",
"     28-33",
"    </a>",
"    ]. Some high-risk patients can be identified from standard 12-lead tracings, including those with alternating left bundle branch block (LBBB) and right bundle branch block (RBBB), or those with RBBB with alternating left anterior and left posterior fascicular block. These patients have the highest progression to complete heart block and should receive pacemakers [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22328/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Similarly, the following findings on EPS suggest an increased risk of progression to higher degree AV block merit pacemaker therapy:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      H-V prolongation &ndash; In patients with symptoms suggesting a bradyarrhythmia, a prolonged H-V interval (&gt;55 milliseconds) warrants pacemaker therapy. In asymptomatic patients with an H-V interval &gt;100 milliseconds, a pacemaker is also indicated [",
"      <a class=\"abstract\" href=\"UTD.htm?21/51/22328/abstract/33,34\">",
"       33,34",
"      </a>",
"      ]. In asymptomatic patients with an H-V interval &gt;70 milliseconds, pacemakers are more controversial [",
"      <a class=\"abstract\" href=\"UTD.htm?21/51/22328/abstract/28,32,33\">",
"       28,32,33",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/2/12326?source=see_link&amp;anchor=H9#H9\">",
"       \"Overview of invasive cardiac electrophysiology studies\", section on 'HV interval'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Response to atrial pacing &ndash; Programmed atrial extrastimuli can be used to determine the effective refractory period of the HPS, which should be &lt;450 milliseconds. Although longer baseline refractory periods are abnormal, in the absence of other abnormalities there is no clearly demonstrated risk of progression to AV block.",
"      <br/>",
"      <br/>",
"      However, the response of refractory periods to pacing may reveal severe HPS disease. As the refractory period of the HPS should shorten with the cycle length, an increasing refractory period with shorter cycle lengths indicates abnormal HPS conduction [",
"      <a class=\"abstract\" href=\"UTD.htm?21/51/22328/abstract/34\">",
"       34",
"      </a>",
"      ]. During incremental atrial pacing, AV block distal to the His bundle or prolongation of the H-V interval at rates less than or equal to 150 beats per minute is pathologic and warrants pacemaker implantation [",
"      <a class=\"abstract\" href=\"UTD.htm?21/51/22328/abstract/34,35\">",
"       34,35",
"      </a>",
"      ]. However, caution should be used to exclude physiologic block at initiation of pacing due to a long-short sequence.",
"     </li>",
"     <li>",
"      Response to pharmacologic challenge &ndash; Certain pharmacologic agents can be used to reveal poor HPS reserve.",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/34/36391?source=see_link\">",
"       Procainamide",
"      </a>",
"      normally prolongs the H-V interval by 10 to 20 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?21/51/22328/abstract/36\">",
"       36",
"      </a>",
"      ]. Doubling of the H-V interval, an H-V interval &gt;100 milliseconds or the development of infra-Hisian block after administering procainamide represent poor HPS reserve and probably mandates permanent pacing (",
"      <a class=\"graphic graphic_waveform graphicRef56786 \" href=\"UTD.htm?8/45/8915\">",
"       waveform 6",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?21/51/22328/abstract/34,37\">",
"       34,37",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Evaluation of HPS conduction can be limited by AV nodal conduction (ie, block in the AV node preventing evaluation of the HPS). In these instances,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?11/23/11640?source=see_link\">",
"       atropine",
"      </a>",
"      is often used to shorten the refractory period of the AV node without affecting HPS conduction [",
"      <a class=\"abstract\" href=\"UTD.htm?21/51/22328/abstract/38\">",
"       38",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Therapeutic implications",
"    </span>",
"    &nbsp;&mdash;&nbsp;In general, block in the AV node is more benign than His-Purkinje system (HPS) disease. This is due to the fact that the catecholamines released in response to exertion improve conduction in the AV node, allowing faster heart rates appropriate to increases in metabolic demand. In addition, His bundle escape rhythms (junctional rhythms) usually occur at rates fast enough to avoid symptoms. In contrast, AV block in the HPS worsens at faster heart rates, usually resulting in exertional symptoms. Escape rhythms associated with HPS block originate in the more distal components of the AV conduction system and are slower and less reliable, often resulting in symptoms and, frequently, hemodynamic compromise. For these reasons, pacemaker therapy is indicated for significant HPS disease regardless of symptoms and usually only in symptomatic AV nodal disease or when essential medical therapy is prohibited.",
"   </p>",
"   <p>",
"    In patients with significant HPS disease, most notably LBBB, there is an increased incidence of cardiac disease, congestive heart failure, AV block, ventricular tachyarrhythmias and sudden death [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22328/abstract/28,29,32,33,39-41\">",
"     28,29,32,33,39-41",
"    </a>",
"    ]. In these patients, careful cardiac evaluation is necessary, often including EPS with ventricular stimulation. Consideration should be given to implantation of dual-chamber or biventricular implantable cardioverter-defibrillators (ICDs) in these situations to prevent sudden death as pacemakers have shown to improve morbidity and relieve symptoms, but not alter mortality.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, \"The Basics\" and \"Beyond the Basics.\" The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on \"patient info\" and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?8/46/8931?source=see_link\">",
"       \"Patient information: Bradycardia (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1812661\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Significant bradyarrhythmias can be divided into two major categories, depending on the anatomic site of origin. Both sinus node (SN) dysfunction and atrioventricular (AV) conduction disorders can lead to symptomatic bradycardia and the need for implantation of a permanent pacemaker.",
"   </p>",
"   <p>",
"    When considering the utility of electrophysiology studies (EPS) in patients with SN dysfunction, the following should be kept in mind:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients who have symptoms that correlate with bradycardia or pauses, or who have electrocardiographic evidence of significant SN dysfunction, generally do not require invasive testing of SN function prior to pacemaker implantation. EPS should be used when bradycardia cannot be clearly associated with symptoms or if the available clinical evidence of SN disease is non-diagnostic. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Sinus node dysfunction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      When EPS are performed in patients with SN dysfunction, an abnormal corrected sinus node recovery time (CSNRT) is more commonly seen than an abnormal sinoatrial conduction time (SACT). Owing to the improved sensitivity and ease of performance of the CSNRT, it is the preferred invasive measurement to evaluate SN function. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Sinus node recovery time'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Invasive measurements of SN function should be considered adjuncts to clinical and noninvasive parameters, as these tests are based upon assumptions that limit their validity and, hence, their clinical utility. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Limitations of SACT'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H9\">",
"       'Limitations of SNRT'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    When considering the utility of EPS in patients with AV conduction disorders, the following should be kept in mind:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with symptomatic spontaneous second and third degree AV block generally do not require EPS prior to pacemaker implantation. Such patients have an indication for pacemaker implantation and the results of EPS would have little impact on management. Invasive EPS are a useful tool in defining AV block when symptoms are poorly correlated with bradyarrhythmias or when surface ECG tracings cannot confidently localize the site of block. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Atrioventricular conduction disturbances'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients with significant AV conduction disorders involving the His-Purkinje system, most notably LBBB, there is an increased incidence of cardiac disease, congestive heart failure, AV block, ventricular tachyarrhythmias and sudden death. As such, when EPS are performed in these patients, it is important to consider performing ventricular stimulation as part of the EPS as a means of risk stratification for ventricular tachyarrhythmias and possible implantable cardioverter-defibrillator placement in patients deemed high risk. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Therapeutic implications'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22328/abstract/1\">",
"      Damato AN, Lau SH, Helfant R, et al. A study of heart block in man using His bundle recordings. Circulation 1969; 39:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22328/abstract/2\">",
"      Mandel W, Hayakawa H, Danzig R, Marcus HS. Evaluation of sino-atrial node function in man by overdrive suppression. Circulation 1971; 44:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22328/abstract/3\">",
"      Narula OS, Scherlag BJ, Samet P, Javier RP. Atrioventricular block. Localization and classification by His bundle recordings. Am J Med 1971; 50:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22328/abstract/4\">",
"      Scherlag BJ, Lau SH, Helfant RH, et al. Catheter technique for recording His bundle activity in man. Circulation 1969; 39:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22328/abstract/5\">",
"      Zipes DP, DiMarco JP, Gillette PC, et al. Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Intracardiac Electrophysiologic and Catheter Ablation Procedures), developed in collaboration with the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol 1995; 26:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22328/abstract/6\">",
"      Tracy CM, Akhtar M, DiMarco JP, et al. American College of Cardiology/American Heart Association 2006 update of the clinical competence statement on invasive electrophysiologystudies,catheterablation,andcardioversion: a report of the American College of Cardiology/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training developed in collaboration with the Heart Rhythm Society. J Am Coll Cardiol 2006; 48:1503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22328/abstract/7\">",
"      Dimarco JP, Garan H, Ruskin JN. Complications in patients undergoing cardiac electrophysiologic procedures. Ann Intern Med 1982; 97:490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22328/abstract/8\">",
"      Horowitz LN, Kay HR, Kutalek SP, et al. Risks and complications of clinical cardiac electrophysiologic studies: a prospective analysis of 1,000 consecutive patients. J Am Coll Cardiol 1987; 9:1261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22328/abstract/9\">",
"      Strauss HC, Bigger JT, Saroff AL, Giardina EG. Electrophysiologic evaluation of sinus node function in patients with sinus node dysfunction. Circulation 1976; 53:763.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22328/abstract/10\">",
"      Narula OS, Shantha N, Vasquez M, et al. A new method for measurement of sinoatrial conduction time. Circulation 1978; 58:706.",
"     </a>",
"    </li>",
"    <li>",
"     Josephson ME. Sinus Node Dysfunction. In: Clinical Cardiac Electrophysiology. Techniques and Interpretations, 3rd ed, Josephson ME (Ed), Lippincott, Philadelphia 2002. p.68.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22328/abstract/12\">",
"      Dhingra RC, Wyndham C, Denes P, et al. Sinus nodal responses to atrial extrastimuli in patients without apparent sinus node disease. Am J Cardiol 1975; 36:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22328/abstract/13\">",
"      Strauss HC, Saroff AL, Bigger JT Jr, Giardina EG. Premature atrial stimulation as a key to the understanding of sinoatrial conduction in man. Presentation of data and critical review of the literature. Circulation 1973; 47:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22328/abstract/14\">",
"      Cramer M, Hariman RJ, Boxer R, Hoffman BF. Electrograms from the canine sinoatrial pacemaker recorded in vitro and in situ. Am J Cardiol 1978; 42:939.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22328/abstract/15\">",
"      Cramer M, Siegal M, Bigger JT Jr, Hoffman BF. Characteristics of extracellular potentials recorded from the sinoatrial pacemaker of the rabbit. Circ Res 1977; 41:292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22328/abstract/16\">",
"      Gomes JA, Kang PS, El-Sherif N. The sinus node electrogram in patients with and without sick sinus syndrome: techniques and correlation between directly measured and indirectly estimated sinoatrial conduction time. Circulation 1982; 66:864.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22328/abstract/17\">",
"      Hariman RJ, Krongrad E, Boxer RA, et al. Method for recording electrical activity of the sinoatrial node and automatic atrial foci during cardiac catheterization in human subjects. Am J Cardiol 1980; 45:775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22328/abstract/18\">",
"      Reiffel JA, Bigger JT Jr. Current status of direct recordings of the sinus node electrogram in man. Pacing Clin Electrophysiol 1983; 6:1143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22328/abstract/19\">",
"      Reiffel JA, Gang E, Gliklich J, et al. The human sinus node electrogram: a transvenous catheter technique and a comparison of directly measured and indirectly estimated sinoatrial conduction time in adults. Circulation 1980; 62:1324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22328/abstract/20\">",
"      Rakovec P, Jakopin J, Rode P, et al. Clinical comparison of indirectly and directly determined sinoatrial conduction time. Am Heart J 1981; 102:292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22328/abstract/21\">",
"      Heddle W, Dorveaux LD, Tonkin AM. Use of rapid atrial pacing to assess sinus node function. Clin Prog Electrophysiol Pacing 1985; 3:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22328/abstract/22\">",
"      Kupersmith J, Krongrad E, Waldo AL. Conduction intervals and conduction velocity in the human cardiac conduction system. Studies during open-heart surgery. Circulation 1973; 47:776.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22328/abstract/23\">",
"      Narula OS, Cohen LS, Samet P, et al. Localization of A-V conduction defects in man by recording of the His bundle electrogram. Am J Cardiol 1970; 25:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22328/abstract/24\">",
"      Josephson ME, Scharf DL, Kastor JA, Kitchen JG. Atrial endocardial activation in man. Electrode catheter technique of endocardial mapping. Am J Cardiol 1977; 39:972.",
"     </a>",
"    </li>",
"    <li>",
"     Josephson ME. Atrioventricular Conduction. Techniques and Interpretations. In: Clinical Cardiac Electrophysiology, Josephson ME (Ed), Lippincott, Philadelphia 2002. p.92.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22328/abstract/26\">",
"      Denes P, Levy L, Pick A, Rosen KM. The incidence of typical and atypical A-V Wenckebach periodicity. Am Heart J 1975; 89:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22328/abstract/27\">",
"      Rosen KM, Rahimtoola SH, Gunnar RM. Pseudo A-V block secondary to premature nonpropagated His bundle depolarizations: documentation by His bundle electrocardiography. Circulation 1970; 42:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22328/abstract/28\">",
"      Dhingra RC, Palileo E, Strasberg B, et al. Significance of the HV interval in 517 patients with chronic bifascicular block. Circulation 1981; 64:1265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22328/abstract/29\">",
"      Dhingra RC, Wyndham C, Amat-y-Leon F, et al. Incidence and site of atrioventricular block in patients with chronic bifascicular block. Circulation 1979; 59:238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22328/abstract/30\">",
"      Kulbertus HE. Reevaluation of the prognosis of patients with LAD--RBBB. Am Heart J 1976; 92:665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22328/abstract/31\">",
"      Lasser RP, Haft JI, Friedberg CK. Relationship of right bundle-branch block and marked left axis deviation (with left parietal or peri-infarction block) to complete heart block and syncope. Circulation 1968; 37:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22328/abstract/32\">",
"      McAnulty JH, Rahimtoola SH, Murphy E, et al. Natural history of \"high-risk\" bundle-branch block: final report of a prospective study. N Engl J Med 1982; 307:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22328/abstract/33\">",
"      Scheinman MM, Peters RW, Suav&eacute; MJ, et al. Value of the H-Q interval in patients with bundle branch block and the role of prophylactic permanent pacing. Am J Cardiol 1982; 50:1316.",
"     </a>",
"    </li>",
"    <li>",
"     Josephson ME. Intraventricular Conduction Disturbances. In: Clinical Cardiac Electrophysiology. Techniques and Interpretations, 3rd ed, Josephson ME (Ed), Lippincott, Philadelphia 2002. p.110.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22328/abstract/35\">",
"      Dhingra RC, Wyndham C, Bauernfeind R, et al. Significance of block distal to the His bundle induced by atrial pacing in patients with chronic bifascicular block. Circulation 1979; 60:1455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22328/abstract/36\">",
"      Josephson ME, Caracta AR, Ricciutti MA, et al. Electrophysiologic properties of procainamide in man. Am J Cardiol 1974; 33:596.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22328/abstract/37\">",
"      Tonkin AM, Heddle WF, Tornos P. Intermittent atrioventricular block: procainamide administration as a provocative test. Aust N Z J Med 1978; 8:594.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22328/abstract/38\">",
"      Akhtar M, Damato AN, Caracta AR, et al. Electrophysiologic effects of atropine on atrioventricular conduction studied by His bundle electrogram. Am J Cardiol 1974; 33:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22328/abstract/39\">",
"      Denes P, Dhingra RC, Wu D, et al. Sudden death in patients with chronic bifascicular block. Arch Intern Med 1977; 137:1005.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22328/abstract/40\">",
"      Dhingra RC, Amat-Y-Leon F, Wyndham C, et al. Significance of left axis deviation in patients with chronic left bundle branch block. Am J Cardiol 1978; 42:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22328/abstract/41\">",
"      Morady F, Higgins J, Peters RW, et al. Electrophysiologic testing in bundle branch block and unexplained syncope. Am J Cardiol 1984; 54:587.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 979 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-122.72.76.133-A161942C46-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_51_22328=[""].join("\n");
var outline_f21_51_22328=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H1812661\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      GENERAL APPROACH",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      SINUS NODE DYSFUNCTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Indirect determination of sinoatrial conduction time",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Limitations of SACT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Direct recording of the sinoatrial conduction time (sinus node electrogram)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Sinus node recovery time",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Limitations of SNRT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      ATRIOVENTRICULAR CONDUCTION DISTURBANCES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Electrophysiologic evaluation of atrioventricular block",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Baseline intervals",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Prolonged AV conduction (first-degree AV block)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Second-degree AV block",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Third-degree (complete) AV block",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Indications for EPS in patients with AV block",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Findings suggestive of high risk",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Therapeutic implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1812661\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/979\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/979|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?20/43/21180\" title=\"figure 1\">",
"      Sinoatrial conduction time",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/979|Waveform\">",
"      <a href=\"#\" title=\"WAVEFORMS\">",
"       WAVEFORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?11/36/11846\" title=\"waveform 1\">",
"      Corrected sinus node recovery time",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?14/58/15267\" title=\"waveform 2\">",
"      Concealed His extrasystole",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?38/63/39935\" title=\"waveform 3\">",
"      2 to 1 block in AV Node",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?22/13/22741\" title=\"waveform 4\">",
"      2 to 1 block within His",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?5/33/5654\" title=\"waveform 5\">",
"      2 to 1 block below His",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?8/45/8915\" title=\"waveform 6\">",
"      Effects of procainamide on conduction",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/54/9064?source=related_link\">",
"      Diagnosis and evaluation of the sick sinus syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/16/32007?source=related_link\">",
"      Etiology of atrioventricular block",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/52/27463?source=related_link\">",
"      Indications for permanent cardiac pacing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/1/3097?source=related_link\">",
"      Invasive cardiac electrophysiology studies: Tachyarrhythmias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/51/40759?source=related_link\">",
"      Lyme carditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/31/22008?source=related_link\">",
"      Manifestations and causes of the sick sinus syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/2/12326?source=related_link\">",
"      Overview of invasive cardiac electrophysiology studies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?8/46/8931?source=related_link\">",
"      Patient information: Bradycardia (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/42/18087?source=related_link\">",
"      Second degree atrioventricular block: Mobitz type I (Wenckebach block)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/62/998?source=related_link\">",
"      Second degree atrioventricular block: Mobitz type II",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/59/15285?source=related_link\">",
"      Third degree (complete) atrioventricular block",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/46/21224?source=related_link\">",
"      Vagal maneuvers",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_51_22329="HUS Glomerular";
var content_f21_51_22329=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F63511&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F63511&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Light micrograph showing renal thrombotic microangiopathy with intracapillary glomerular thrombi",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 243px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Light micrograph showing multiple intracapillary glomerular thrombi (arrows) typical of a thrombotic microangiopathy as can be seen in any of the forms of the hemolytic-uremic syndrome.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal glomerulus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 253px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Light micrograph of a normal glomerulus. There are only 1 or 2 cells per capillary tuft, the capillary lumens are open, the thickness of the glomerular capillary wall (long arrow) is similar to that of the tubular basement membranes (short arrow), and the mesangial cells and mesangial matrix are located in the central or stalk regions of the tuft (arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut G Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_51_22329=[""].join("\n");
var outline_f21_51_22329=null;
var title_f21_51_22330="Hypermetabolic response to severe burn injury: Recognition and treatment";
var content_f21_51_22330=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Hypermetabolic response to severe burn injury: Recognition and treatment",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/51/22330/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/51/22330/contributors\">",
"     Gerd G Gauglitz, MMS, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/51/22330/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/51/22330/contributors\">",
"     Marc G Jeschke, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/51/22330/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/51/22330/contributors\">",
"     Rosemary B Duda, MD, MPH, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/51/22330/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 16, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The hypermetabolic response in burn patients is characterized by hyperdynamic circulatory, physiologic, catabolic, and immune system responses. Attenuation of the hypermetabolic response occurs by altering the physiological and biochemical environment. The administration of specific nutrients, growth factors, and other agents is emerging as an essential component of the management of burned, trauma, and critically ill patients [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The metabolic changes that occur following moderate to severe burn injuries and the attenuation of the hypermetabolic response and hyperglycemia will be discussed here. The overview of nutritional support, evaluation of nutritional support, and the nutritional demands and enteral formulas are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/7/4215?source=see_link\">",
"     \"Overview of nutritional support for moderate to severe burn patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/22/15716?source=see_link\">",
"     \"Evaluating nutritional support for moderate to severe burn patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/8/11401?source=see_link\">",
"     \"Nutritional demands and enteral formulas for moderate to severe burn patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     HYPERMETABOLIC CHANGES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Definition",
"    </span>",
"    &nbsp;&mdash;&nbsp;The hypermetabolic response in burn patients is characterized by a hyperdynamic circulatory response with massive protein and lipid catabolism, total body protein loss, muscle wasting, peripheral insulin resistance, increased energy expenditure, increased body temperature, increased infection risks, and stimulated synthesis of acute phase proteins located in the liver and intestinal mucosa [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/1-7\">",
"     1-7",
"    </a>",
"    ]. Early recognition and treatment of these profound metabolic changes improves clinical outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/3-5\">",
"     3-5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These responses occur in all trauma, surgical, or critically ill patients, but the severity, duration, and magnitude is uniquely severe for burn patients [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/4\">",
"     4",
"    </a>",
"    ]. Marked and sustained increases in catecholamine, glucocorticoid, glucagons, and dopamine secretion initiate the cascade of events leading to the acute hypermetabolic response with its ensuing catabolic state [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/6,8-15\">",
"     6,8-15",
"    </a>",
"    ]. The hypermetabolic state begins within five days of a major burn injury and persists for as long as one year [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/7/4215?source=see_link\">",
"     \"Overview of nutritional support for moderate to severe burn patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/32/13831?source=see_link\">",
"     \"Nutrition support in critically ill patients: An overview\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/37/28249?source=see_link\">",
"     \"Glucocorticoid effects on the immune system\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Frequency",
"    </span>",
"    &nbsp;&mdash;&nbsp;The metabolic rate increases proportionally to the increase in burn size [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/17\">",
"     17",
"    </a>",
"    ]. A 15 to 25 percent total body surface area (TBSA) burn injury initiates a catabolic response, including impaired immunity and fluid shifts [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/18\">",
"     18",
"    </a>",
"    ]. Adults with a 25 percent (TBSA) burn injury develop a metabolic rate between 118 to 210 percent of that predicted by Harris Benedict equations for basal metabolic rate [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/19\">",
"     19",
"    </a>",
"    ]. Those with burns greater than 40 percent TBSA always experience hypermetabolism [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/16\">",
"     16",
"    </a>",
"    ]. A further increase in hypermetabolism occurs in patients with burns of 50 to 60 percent TBSA, after which there is minimal further increase in catabolic rate [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A prospective, longitudinal study found that children with burn injuries greater than 40 percent TBSA develop a metabolic rate of 180 percent of the basal metabolic rate during the acute admission, persist with an elevated rate of 150 percent following complete wound closure, and maintain a 110 percent rate at one year [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/4,6\">",
"     4,6",
"    </a>",
"    ]. Resting energy expenditure was measured by indirect calorimetry, stable isotope study, and body composition. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/22/15716?source=see_link\">",
"     \"Evaluating nutritional support for moderate to severe burn patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Etiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cause of this complex response is not well understood. Interleukins 1 and 6, platelet-activating factor, tumor necrosis factor (TNF), endotoxin, neutrophil-adherence complexes, reactive oxygen species, nitric oxide, and coagulation and complement cascades have been implicated in regulating this response to burn injury [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/21\">",
"     21",
"    </a>",
"    ]. Once these cascades are initiated, their mediators and byproducts appear to stimulate the persistent and increased metabolic rate associated with altered glucose metabolism seen after severe burn injury [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/22\">",
"     22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/58/6056?source=see_link\">",
"     \"The adaptive cellular immune response\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/62/27624?source=see_link\">",
"     \"The humoral immune response\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/8/4231?source=see_link\">",
"     \"Role of cytokines in the immune system\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/42/38569?source=see_link\">",
"     \"Acute phase reactants\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/6/34921?source=see_link\">",
"     \"Mast cell derived mediators\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/55/40825?source=see_link\">",
"     \"Tumor necrosis factor-alpha inhibitors: An overview of adverse effects\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Duration",
"    </span>",
"    &nbsp;&mdash;&nbsp;The hypermetabolic response to burn injury may last for more than 12 months after the initial event and is not resolved after wound closure [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/6,8,15,16,23\">",
"     6,8,15,16,23",
"    </a>",
"    ]. Sustained hypermetabolic alterations, indicated by persistent elevations of the stress mediators (24 hour urine cortisol levels, serum cytokines, catecholamines, and basal energy requirements) are accompanied by impaired glucose metabolism and insulin sensitivity that persist for up to three years after the severe burn injury [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     PATTERNS OF METABOLIC REGULATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two distinct patterns of metabolic regulation following injury are described [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Ebb phase",
"    </span>",
"    &nbsp;&mdash;&nbsp;Classically referred to as the \"ebb phase&rdquo;, these changes occur within the first 48 hours of a burn injury [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. This phase is characterized by decreased cardiac output, oxygen consumption, and metabolic rate, as well as impaired glucose tolerance and hyperglycemia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Flow phase",
"    </span>",
"    &nbsp;&mdash;&nbsp;The flow phase represents a gradual increase in metabolism to reach a plateau within the first five days post-injury. This phase is associated with hyperdynamic circulation and the hypermetabolic state. Insulin release during this time period is found to be twice that of controls in response to glucose load [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/27,28\">",
"     27,28",
"    </a>",
"    ], and plasma glucose levels are markedly elevated, indicating the progression of insulin resistance [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/58/25511?source=see_link\">",
"     \"Insulin action\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     GLUCOSE METABOLISM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Glucose metabolism in healthy subjects and patients with diabetes is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29638?source=see_link&amp;anchor=H2#H2\">",
"     \"Physiologic response to hypoglycemia in normal subjects and patients with diabetes mellitus\", section on 'Regulation of glucose homeostasis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/58/25511?source=see_link\">",
"     \"Insulin action\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/46/41702?source=see_link\">",
"     \"Insulin secretion and pancreatic beta-cell function\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Normal response",
"    </span>",
"    &nbsp;&mdash;&nbsp;Under normal circumstances, a postprandial increase in blood glucose concentration stimulates release of insulin from pancreatic beta-cells. Insulin mediates peripheral glucose uptake into skeletal muscle and adipose tissue and suppresses hepatic gluconeogenesis, thereby maintaining blood glucose homeostasis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29638?source=see_link&amp;anchor=H2#H2\">",
"     \"Physiologic response to hypoglycemia in normal subjects and patients with diabetes mellitus\", section on 'Regulation of glucose homeostasis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Stress response",
"    </span>",
"    &nbsp;&mdash;&nbsp;In critical illness, metabolic alterations can cause significant changes in energy substrate metabolism. In order to provide glucose, release of stress mediators opposes the anabolic actions of insulin. By enhancing adipose tissue lipolysis and skeletal muscle proteolysis, stress mediators (ie, counterregulatory hormones) increase gluconeogenic substrates, including glycerol, alanine, and lactate, thus augmenting hepatic glucose production in burned patients [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/30-33\">",
"     30-33",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29638?source=see_link&amp;anchor=H4#H4\">",
"     \"Physiologic response to hypoglycemia in normal subjects and patients with diabetes mellitus\", section on 'Counterregulatory hormones'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hyperglycemia fails to suppress hepatic glucose release during this time and the suppressive effect of insulin on hepatic glucose release is attenuated, significantly contributing to persistent post-trauma hyperglycemia [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/24,34,35\">",
"     24,34,35",
"    </a>",
"    ]. Catecholamine-mediated enhancement of hepatic glycogenolysis, as well as direct sympathetic stimulation of glycogen breakdown, can further aggravate the hyperglycemia in response to stress [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/31\">",
"     31",
"    </a>",
"    ]. Catecholamines have also been shown to impair glucose disposal via alterations of the insulin-signaling pathway and GLUT-4 translocation muscle and adipose tissue, resulting in peripheral insulin resistance [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/30,36\">",
"     30,36",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/58/25511?source=see_link&amp;anchor=H6#H6\">",
"     \"Insulin action\", section on 'Glucose utilization'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     PROTEIN AND LIPID METABOLISM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Alterations in metabolic pathways and pro-inflammatory cytokines, such as TNF, have significantly contributed to lean muscle protein breakdown, both during the acute and convalescent phases in response to burn injury [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/8/4231?source=see_link\">",
"     \"Role of cytokines in the immune system\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/55/40825?source=see_link\">",
"     \"Tumor necrosis factor-alpha inhibitors: An overview of adverse effects\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In contrast to starvation, in which lipolysis and ketosis provide energy and protect muscle reserves, burn injury considerably reduces the ability of the body to utilize lipids as an energy source. Skeletal muscle is the major source of fuel, which leads to marked wasting of lean body mass (LBM) within days after injury [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/4,39\">",
"     4,39",
"    </a>",
"    ]. Since skeletal muscle has been shown to be responsible for 70 to 80 percent of whole body insulin-stimulated glucose uptake, decreases in muscle mass may significantly contribute to this persistent insulin resistance post-burn [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/40\">",
"     40",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/57/28567?source=see_link\">",
"     \"Insulin resistance: Definition and clinical spectrum\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A 10 to 15 percent loss in LBM is associated with significant increases in infection rate and marked delays in wound healing [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/41\">",
"     41",
"    </a>",
"    ]. The resultant muscle weakness further prolongs mechanical ventilatory requirements, inhibits sufficient cough reflexes, and delays mobilization in protein-malnourished patients, thus markedly contributing to the incidence of mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/42\">",
"     42",
"    </a>",
"    ]. Persistent protein catabolism may also account for growth and developmental delay frequently observed in the pediatric patient population with burns covering greater than 40 percent TBSA [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     THERAPEUTIC APPROACHES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Therapeutic approaches focus on attenuating or blunting the hypermetabolic response with its ensuing catabolic state. A number of different strategies are used to alter the physiologic and biochemical environment.",
"   </p>",
"   <p>",
"    The hypermetabolic response can be attenuated using nonpharmacologic and pharmacologic modalities. The nonpharmacologic modalities include early wound excision and closure, nutritional support, environmental support, and exercise and adjunctive measures. The pharmacologic modalities include",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/54/12137?source=see_link\">",
"     recombinant human growth hormone",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/28/39364?source=see_link\">",
"     oxandrolone",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/49/8986?source=see_link\">",
"     propranolol",
"    </a>",
"    . These are addressed in the following sections.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     NONPHARMACOLOGIC ATTENUATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Early wound closure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early excision of necrotic tissue and closure of the burn wound has been one of the single greatest advancements in the treatment of patients with severe thermal injuries and a mainstay of therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/4,6,44\">",
"     4,6,44",
"    </a>",
"    ]. A single institution retrospective analysis of 3561 burn patients attributed early wound excision and closure (day one to five) to the decrease in length of hospital stay and the reduced cost of hospital care [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A meta-analysis of six prospective trials showed a significant reduction in mortality with early excision and grafting in burn patients without inhalation injury (RR 0.36, 95 percent CI 0.20 to 0.65) compared to conservative treatment of dressing changes and delayed skin grafts following eschar separation [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/44\">",
"     44",
"    </a>",
"    ]. The pooled data showed that then mean length of hospital stay was significantly shorter for the early excision group (standardized mean difference (SMD) -8.89) and the requirement for blood transfusions was significantly higher (SMD 1.65). There was no difference in duration of sepsis, wound healing time and skin graft take between the two groups.",
"   </p>",
"   <p>",
"    While burn wound closure within the first five days is optimal, it is not always possible. A retrospective study of 143 burn patients showed that a delayed primary wound closure (day 6 to 12) had a similar advantage of early wound closure in reducing risk of septicemia, mortality, morbidity, hospital stay, and cost of treatment, in comparison to 449 patients treated with delayed closure, a practice that allowed wounds to granulate prior to skin grafting [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Early wound closure is also associated with decreased severity of hypertrophic scarring, joint contractures and stiffness, and promotes faster rehabilitation [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/47,48\">",
"     47,48",
"    </a>",
"    ]. Wound closure alone, however, does not eliminate the hypermetabolic response [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Biological and synthetic substrates",
"    </span>",
"    &nbsp;&mdash;&nbsp;Biological and synthetic substrates have been employed to cover burns. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Autografts &mdash; Autografts from the uninjured skin of the burn patient remain the mainstay of treatment for coverage of the burn wound.",
"     </li>",
"     <li>",
"      Isografts &mdash; These grafts are obtained from a monozygotic twin. Rejection of the isograft rarely occurs.",
"     </li>",
"     <li>",
"      Allografts &mdash; Since early wound closure using autografts may be difficult when full-thickness burns exceed 40 percent total TBSA, allografts derived from cadaver skin serve as a skin substitute in severely burned patients. While this approach is still commonly used worldwide, it bears considerable risks, including antigenicity and cross-infection [",
"      <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/49\">",
"       49",
"      </a>",
"      ]. Allografts are to be used as a temporary wound closure only.",
"     </li>",
"     <li>",
"      Tissue engineering &mdash; Tissue engineering technology is advancing rapidly. The culture of human keratinocytes from the burn patient has made it possible to obtain large amounts of cultured epithelium from a small skin biopsy within three to four weeks following a burn. Widespread use is limited secondary to poor long term clinical results, exorbitant costs, and fragility of the graft [",
"      <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/50-54\">",
"       50-54",
"      </a>",
"      ]. Human skin tissue obtained from a national tissue bank is aseptically processed to remove the epidermis and cells that lead to tissue rejection and graft failure. The result is an intact acellular matrix of natural biological components that promotes rapid revascularization, white cell migration, and cell repopulation. The matrix provides a scaffold for cellular invasion and capillary growth and eventually remodels and allows the body to mount its own tissue regeneration process and rebuild the damaged site.",
"      <br/>",
"      <br/>",
"      The advantages of engineered grafts include immediate wound coverage; coverage over exposed bones, tendons, cartilage, and joints with a high level of patient comfort; harvesting of thinner allografts; faster healing of donor site; and early mobilization and improved patient outcomes. Engineered grafts may be invaluable for the extensively burned patient with limited unburned native skin available for skin graft harvesting. These grafts may also be stored for long periods of time at room temperature [",
"      <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/55-62\">",
"       55-62",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Fetal skin constructs have recently been successfully tested [",
"      <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/63\">",
"       63",
"      </a>",
"      ]. Advances in stem cell culture technology are expected to deliver full cosmetic restoration for burn patients [",
"      <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/64\">",
"       64",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Xenografts &mdash; Xenografts, which are grafts obtained from another species, have been used for hundreds of years as temporary replacement for skin loss. Even though these grafts provide a biologically active dermal matrix, the immunologic disparities prevent engraftment and predetermine rejection over time [",
"      <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/50\">",
"       50",
"      </a>",
"      ]. Xenografts are only a temporary burn wound cover.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Nutritional support",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adequate nutrition is imperative for the treatment of severely burned and critically ill patients to reduce the catabolic effects of the injury or illness [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/65\">",
"     65",
"    </a>",
"    ]. For the stable severely burned patient, we suggest the initiation of low",
"    <span class=\"nowrap\">",
"     fat/high",
"    </span>",
"    carbohydrate enteral feedings in adults and children within 24 to 48 hours of the injury. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/7/4215?source=see_link\">",
"     \"Overview of nutritional support for moderate to severe burn patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Energy expenditure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Due to the significant increase in energy expenditure post-burn, high-calorie nutritional support was once believed to decrease muscle metabolism [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/66\">",
"     66",
"    </a>",
"    ]. A randomized trial of 39 patients with greater than 50 percent TBSA burn found a higher mortality with a high calorie combination of parenteral plus enteral nutrition compared with enteral feeding alone (63 versus 26 percent). Intravenous supplementation decreased the amount of enteral calories tolerated by burn patients [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/67\">",
"     67",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The timing of initiating nutritional support is controversial. In a meta-analysis of three trials (70 adult burn patients) evaluating early (within 24 hours) versus late enteral nutrition support, no conclusive evidence was found to support the benefit of early enteral feedings on outcomes of decreased length of hospital stay or mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/68\">",
"     68",
"    </a>",
"    ]. In the hemodynamically stable patient, we suggest initiating enteral nutritional support at least by day two. In unstable patients, nutritional support should be started as soon as patients can tolerate feedings. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/17/34073?source=see_link\">",
"     \"Nutrition support in critically ill patients: Enteral nutrition\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/58/8102?source=see_link\">",
"     \"Nutrition support in critically ill patients: Parenteral nutrition\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/32/6664?source=see_link\">",
"     \"Perioperative nutritional support\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/7/4215?source=see_link\">",
"     \"Overview of nutritional support for moderate to severe burn patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Energy expenditure formulas",
"    </span>",
"    &nbsp;&mdash;&nbsp;Various formulations and equations have been developed to address the specific energy requirements of adult and pediatric burn patients [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/69-73\">",
"     69-73",
"    </a>",
"    ]. The most widely used formula is the Curreri formula [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/73\">",
"     73",
"    </a>",
"    ]. Although avoidance of underfeeding and overfeeding is highly recommended for the burn patient, most of these formulas overestimate the amount of calories required. The specific formulas and methods to calculate energy requirements and expenditure are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/8/11401?source=see_link\">",
"     \"Nutritional demands and enteral formulas for moderate to severe burn patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/7/4215?source=see_link\">",
"     \"Overview of nutritional support for moderate to severe burn patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Essential fatty acids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Essential fatty acid deficiency is a well-documented complication in hospital patients receiving long-term nutritional supplements and subsequently is corrected by providing a significant amount of caloric requirements as lipids [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/20\">",
"     20",
"    </a>",
"    ]. This approach reduces the requirements for carbohydrates and can improve burn-induced glucose intolerance [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/39\">",
"     39",
"    </a>",
"    ]. For these reasons, dietary composition containing 30 to 50 percent lipids have become commonplace in the therapy of critically ill patients throughout the world [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/39\">",
"     39",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/32/13831?source=see_link\">",
"     \"Nutrition support in critically ill patients: An overview\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, burn patients require a different type of nutritional support. Several studies have indicated that increased lipid administration may lead to increased complications, including hyperlipidemia, hypoxemia, fatty liver infiltration, higher incidence of infection, and higher postoperative mortality rates in the burned patient population [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/74-76\">",
"     74-76",
"    </a>",
"    ]. Livers of burn patients secrete less very low density lipoprotein (VLDL), and this contributes significantly to triglyceride accumulation in the liver [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/77\">",
"     77",
"    </a>",
"    ]. Hence, the extent to which exogenous lipids can be utilized as an energy source after burn is considerably limited [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/20,32,78\">",
"     20,32,78",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/22/15716?source=see_link\">",
"     \"Evaluating nutritional support for moderate to severe burn patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/8/11401?source=see_link\">",
"     \"Nutritional demands and enteral formulas for moderate to severe burn patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Glycemic targets",
"    </span>",
"    &nbsp;&mdash;&nbsp;Critically ill medical and surgical patients who are hyperglycemic have a higher mortality rate than patients who are normoglycemic. The nutritional management of patients with moderate to severe burns includes avoidance of hyperglycemia. (See",
"    <a class=\"local\" href=\"#H28\">",
"     'Insulin'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/23/28023?source=see_link\">",
"     \"Glycemic control and intensive insulin therapy in critical illness\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Environmental support",
"    </span>",
"    &nbsp;&mdash;&nbsp;Burn patients can lose as much as 4000",
"    <span class=\"nowrap\">",
"     mL/m2",
"    </span>",
"    <span class=\"nowrap\">",
"     burned/day",
"    </span>",
"    of body water through evaporative loss from extensive burn wounds that have not healed or not covered by grafts [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/79\">",
"     79",
"    </a>",
"    ]. The altered physiologic state partly generates sufficient energy to offset heat losses associated with inevitable water loss. The body attempts to raise skin and core temperatures to 2&ordm;C greater than normal. A prospective study found that raising the ambient temperature from 25&ordm;C to 33&ordm;C diminished the magnitude of this obligatory response from 2.0 to 1.4 times resting energy expenditure [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/80\">",
"     80",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Exercise and adjunctive measures",
"    </span>",
"    &nbsp;&mdash;&nbsp;A balanced physical therapy program is essential to restore metabolic variables and prevent burn wound contractures. In a randomized trial of progressive resistance and aerobic exercises versus traditional outpatient home therapy in 21 children, both groups had a significant increase in muscle strength compared with baseline [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/81\">",
"     81",
"    </a>",
"    ]. However, the study group had significantly greater improvements in muscle strength (80 versus 38 percent in the home group). The study group also improved the distance walked (40 versus 12 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     PHARMACOLOGIC ATTENUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the initial burn injury and sepsis-related complications principally determine the extent of the metabolic response in burn victims, obligatory activity, background and procedural related pain, and anxiety also greatly increase metabolic rates. Judiciously maximizing narcotics support, appropriate sedation, and supportive psychotherapy are mandatory to minimize their effects [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/82\">",
"     82",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Specific pharmacotherapies that can attenuate the hypermetabolic response include pain relievers, anabolic hormones, anabolic steroids, and catecholamine antagonists [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some pharmacotherapies are more effective in the acute rather than chronic phase of the burn injury. The acute phase is defined as the period immediately following the resuscitation phase, when the patient is hemodynamically stable, capillary permeability is restored, and diuresis has begun. It generally starts 48 to 72 hours post burn injury. The chronic or rehabilitation phase begins when wounds are healed.",
"   </p>",
"   <p>",
"    We recommend for adults and children aggressive pain control using opioids acutely, insulin",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    to maintain blood glucose levels between 110 and 150, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/28/39364?source=see_link\">",
"     oxandrolone",
"    </a>",
"    in the acute and chronic phases. rhGH is recommended only in children and only in the chronic phase of burn care.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Analgesia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The metabolic rate of the burn patient is adversely affected by pain, anxiety, and activity [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/3\">",
"     3",
"    </a>",
"    ]. Because burn injuries cause one of the most intense and prolonged types of pain, pain management is important to attenuate the hypermetabolic response. Intravenous opioids, continuous or bolused, are most often used to relieve pain. Supportive psychotherapy is helpful in reducing patient anxiety [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/83\">",
"     83",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/23/34169?source=see_link\">",
"     \"Burn pain: Principles of pharmacologic and nonpharmacologic management\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/50/38695?source=see_link\">",
"     \"Paradigm-based treatment approaches for burn pain control\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Oxandrolone",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment with anabolic steroids such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/28/39364?source=see_link\">",
"     oxandrolone",
"    </a>",
"    , a testosterone analog with a low level of virilizing androgenic effects, improves muscle protein catabolism via enhanced protein synthesis efficiency, reduces weight loss, and increases donor site wound healing [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/84,85\">",
"     84,85",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a randomized trial of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/28/39364?source=see_link\">",
"     oxandrolone",
"    </a>",
"    (10 mg every 12 hours) versus placebo in 81 adult burn patients, a planned interim analysis showed that the oxandrolone group had a significantly shorter hospital stay (31.6 versus 43.3 with placebo) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/86\">",
"     86",
"    </a>",
"    ]. The trial was halted early due to this finding. In a separate study, the improvement in lean body mass with oxandrolone and the subsequent decrease in length of stay were independent of age [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/87\">",
"     87",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/28/39364?source=see_link\">",
"     Oxandrolone",
"    </a>",
"    is also beneficial in children. In a randomized trial of standard care plus oxandrolone versus standard care alone during the acute phase of burn care in 235 children, oxandrolone reduced hospital stay (0.48 versus 0.56 days per percent burn), maintained lean body mass, improved body composition and improved hepatic protein synthesis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/88\">",
"     88",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In other randomized trials of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/28/39364?source=see_link\">",
"     oxandrolone",
"    </a>",
"    (0.1",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    twice daily) versus placebo in children with moderate to severe burns, LBM, bone mineral content, and bone mineral density were significantly better in the oxandrolone group [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/89,90\">",
"     89,90",
"    </a>",
"    ]. The benefits persisted for five years after the burn injury, with maximal effect identified in patients aged 7 to 18 years [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/90\">",
"     90",
"    </a>",
"    ]. It must be noted that although anabolic steroids can increase lean body mass, exercise is essential to developing strength [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/90,91\">",
"     90,91",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Insulin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Insulin infusions are used to treat hyperglycemia in severely burned patients with diabetes mellitus. In addition, intravenous insulin is frequently used to treat stress-related hyperglycemia in patients without a past history of diabetes.",
"   </p>",
"   <p>",
"    The ideal target glucose range has not been identified and clinical trials are being conducted to define ideal glucose levels for the treatment of critically ill, trauma, and severely burned patients. The potential benefit of improved glycemic control must be weighed against the increased risk of hypoglycemia and associated consequences. Glycemic control in critically ill patients is reviewed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/23/28023?source=see_link\">",
"     \"Glycemic control and intensive insulin therapy in critical illness\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In severely burned patients, insulin administered during acute hospitalization has been shown to improve muscle protein synthesis, accelerate donor site healing time, and attenuate lean body mass loss and the acute phase response [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/92-100\">",
"     92-100",
"    </a>",
"    ]. The following randomized trials illustrate the benefits of intensive insulin treatment:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients (n = 18) treated with intravenous insulin at a rate of at least 1.5",
"      <span class=\"nowrap\">",
"       microU/kg/min",
"      </span>",
"      to maintain serum glucose levels between 100 and 140",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (5.6 to 7.8",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      had improved lean body mass and bone mass, and decreased peripheral muscle wasting and length of stay compared with patients who had received placebo (no insulin) therapy [",
"      <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/94\">",
"       94",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Severely burned pediatric patients (n = 239) who received intensive insulin treatment (defined as maintaining glucose levels between 80 and 110",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      or 4.4 and 6.1",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      had significantly fewer septic episodes compared with the patients who served as placebo controls (no intensive insulin therapy) (4 of 49 [8 percent] versus 31 of 137 [23 percent] patients) [",
"      <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/100\">",
"       100",
"      </a>",
"      ]. The mortality rate was also lower for the insulin treated patients (2 versus 15 patients), despite these patients having a larger area of third-degree burn. The insulin treated patients also demonstrated improved organ function, alleviated post-burn insulin resistance and the vast catabolic response to burn injury associated with significantly reduced mortality when compared to controls.",
"     </li>",
"     <li>",
"      Severely burned pediatric patients (n = 208) treated with insulin to maintain a morning (6 AM) blood glucose level of 130",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (7.2",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      demonstrated significantly lower incidences of sepsis and mortality compared with patients who had poor glucose control (6 of 60 [10 percent] versus 36 of 148 [24 percent] patients and 0 versus 17 of 148 [12 percent], respectively) [",
"      <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/101\">",
"       101",
"      </a>",
"      ]. A daily blood glucose average of 140",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (7.8",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      for at least 70 percent of the hospitalization was needed to achieve the improved outcomes.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other approaches to decrease hyperglycemia in burn patients without increasing the risk of hypoglycemia include incretin-based therapies. The incretins include glucose-dependent insulinotropic peptide (GIP) and glucagon-like-peptide-1 (GLP-1). Exogenous GLP-1 reduces glucose concentration in patients with type 2 diabetes after major surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/102\">",
"     102",
"    </a>",
"    ] and those who are critically ill, without diabetes and receiving enteral nutrition [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/103\">",
"     103",
"    </a>",
"    ]. In a prospective trial that included 24 severely burned patients,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/2/14375?source=see_link\">",
"     exenatide",
"    </a>",
"    , a synthetic peptide that possesses incretin-mimetic actions including suppression of glucagon secretion and activation of GLP-1, significantly decreased the amount of exogenous insulin required to maintain glucose levels between 80 and 140",
"    <span class=\"nowrap\">",
"     mg/dl",
"    </span>",
"    (4.4 to 7.8",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/104\">",
"     104",
"    </a>",
"    ]. The GLP-1 analogue tested in this trial appears to be safe and reliably modulated glucose in these patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/35/43577?source=see_link&amp;anchor=H17#H17\">",
"     \"Initial management of blood glucose in type 2 diabetes mellitus\", section on 'Glucagon-like peptide 1 agonists'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition to its anabolic actions, insulin exerts anti-inflammatory effects, potentially neutralizing the pro-inflammatory actions of glucose [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/97\">",
"     97",
"    </a>",
"    ]. These results suggest a dual benefit of insulin administration: reduction of pro-inflammatory effects of glucose by restoration of euglycemia and a proposed additional insulin-mediated anti-inflammatory effect [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/105\">",
"     105",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Maintaining a continuous insulin infusion in burn patients is particularly difficult since these patients are being continuously fed large caloric loads via enteral feeding tubes in an attempt to maintain euglycemia. Since burn patients require frequent operations and dressing changes, enteral nutrition is intermittently halted, which may lead to disruption of gastrointestinal motility and increased risk of hypoglycemia [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/4\">",
"     4",
"    </a>",
"    ]. In addition, insulin resistance can develop during the acute phase and persist for three years in pediatric burn patients [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/24\">",
"     24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/39/26233?source=see_link&amp;anchor=H19#H19\">",
"     \"Management of diabetes mellitus in hospitalized patients\", section on 'Patients receiving enteral or parenteral feedings'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Metformin",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     Metformin",
"    </a>",
"    , a biguanide, reduces blood sugar in patients with type 2 diabetes mellitus. In a pilot study, metformin similarly improved glucose in 10 burn patients [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/106\">",
"     106",
"    </a>",
"    ]. By inhibiting gluconeogenesis and augmenting peripheral insulin sensitivity, metformin directly counters the two main metabolic processes that underlie injury-induced hyperglycemia [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/107-110\">",
"     107-110",
"    </a>",
"    ]. As an example, in a study of six burn patients, metformin increased fractional rate of muscle protein synthesis and improved net muscle protein balance [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/109\">",
"     109",
"    </a>",
"    ]. Therefore, metformin may also have efficacy in critically injured patients as an antihyperglycemic and muscle protein anabolic agent. However, there are insufficient data to support the use of metformin in moderate to severe burn patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/26/38312?source=see_link\">",
"     \"Metformin in the treatment of diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Recombinant human growth hormone",
"    </span>",
"    &nbsp;&mdash;&nbsp;Delays in growth are frequently observed in children who suffer severe burns. It is hypothesized that the delay in vertical growth is related to a low serum level of growth hormone. In a two-year observational study in children with moderate to severe burns, there was a significant difference in height velocity in 38 children treated with rhGH compared with 41 children who did not receive rhGH (47th versus 32nd percentile) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/111\">",
"     111",
"    </a>",
"    ]. However, rhGH did not attenuate the hypermetabolic response.",
"   </p>",
"   <p>",
"    Neither short nor long-term administration of rhGH was associated with an increase in mortality in severely burned children [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/112,113\">",
"     112,113",
"    </a>",
"    ]. However, rhGH is associated with an increase in mortality in adult burn patients and is not recommended in this population [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/114\">",
"     114",
"    </a>",
"    ]. For children, we use rhGH only during the chronic phase of burn management, and rhGH should",
"    <strong>",
"     not",
"    </strong>",
"    be used concurrent with an infection or sepsis. Administration during the acute phase it is associated with an increased risk of septic events [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/111,114-118\">",
"     111,114-118",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Propranolol",
"    </span>",
"    &nbsp;&mdash;&nbsp;Beta-adrenergic blockade with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/49/8986?source=see_link\">",
"     propranolol",
"    </a>",
"    represents the most efficacious anti-catabolic therapy in the treatment of burns. Effective beta blockade blunts the effects of elevated catecholamines, resulting in decreased cardiac oxygen demand and decreased resting metabolism. Beta-blockade attenuates the hypermetabolism in pediatric burn patients and may be beneficial in adult burn patients [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/119-121\">",
"     119-121",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/17/275?source=see_link\">",
"     \"Beta blockers in the treatment of hyperthyroidism\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/39/3704?source=see_link\">",
"     \"Major side effects of beta blockers\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In a randomized trial of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/49/8986?source=see_link\">",
"     propranolol",
"    </a>",
"    versus no placebo in 25 pediatric severe burn patients, propranolol significantly decreased heart rate and resting energy expenditure [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/119\">",
"     119",
"    </a>",
"    ]. The net muscle protein balance, which is the difference between protein synthesis and breakdown, was increased by 82 percent over baseline in the propranolol group compared to no significant change in the untreated control group.",
"   </p>",
"   <p>",
"    Beta-blockers also have the potential to improve adult and pediatric burn outcomes. A small retrospective cohort study of adult burn patients found an association between pre-injury treatment with beta blockers and both a reduction in burn-related mortality and improved wound healing [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/120\">",
"     120",
"    </a>",
"    ]. There was no evidence that post-burn injury treatment with beta-blockers reduced the mortality rate in adult burn patients. A prospective, intent to treat trial (n = 245) found that treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/49/8986?source=see_link\">",
"     propranolol",
"    </a>",
"    in adults (10 to 20 mg three times a day) and children (4",
"    <span class=\"nowrap\">",
"     mg/kg/24",
"    </span>",
"    hours) resulted in significantly fewer infections and sepsis compared with placebo managed patients (21 versus 30 percent and 7 versus 10 percent, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/122\">",
"     122",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/49/8986?source=see_link\">",
"     Propranolol",
"    </a>",
"    reduced fatty infiltration of the liver, which typically occurs as the result of enhanced peripheral lipolysis and altered substrate handling. Propranolol reduced hepatic fat content by decreased peripheral lipolysis and reduced palmitate delivery and uptake by the liver, producing smaller livers and less adverse effects on the function of the diaphragm [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/76,123\">",
"     76,123",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Stable isotope and serial body composition studies showed that administration of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/49/8986?source=see_link\">",
"     propranolol",
"    </a>",
"    reduces skeletal muscle wasting and increases lean body mass post-burn [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/124\">",
"     124",
"    </a>",
"    ]. The underlying mechanism of action of propranolol is still unclear; however, it may cause an increase in protein synthesis in response to persistent protein breakdown and reduced peripheral lipolysis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/51/22330/abstract/125\">",
"     125",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The profound metabolic alterations affecting patients suffering from moderate to severe burns are associated with persistent changes in glucose, protein and lipid metabolism, and impaired insulin sensitivity. Significant advances in the treatment of these patients have been made to attenuate the hypermetabolic response to improve the clinical outcomes. However, effective therapeutic approaches to overcome persistent hypermetabolism and hyperglycemia remain challenging.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The hypermetabolic response in burn patients is characterized by a hyperdynamic circulatory response with massive protein and lipid catabolism, total body protein loss, muscle wasting, peripheral insulin resistance, increased energy expenditure, increased body temperature, increased infection risks, and stimulated synthesis of acute phase proteins located in the liver and intestinal mucosa. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Definition'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Early excision and closure of the burn wound has been the single greatest advancement in treating patients with severe thermal injuries during the last 20 years, leading to substantially reduced resting energy requirements and subsequent improvement of mortality rates. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Nonpharmacologic attenuation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Early excision and coverage of burn wounds with autologous skin grafts reduces the risk of septicemia, mortality, morbidity, and length of hospital stay. Biological and synthetic substrates are alternative options when access to autografts is limited. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Nonpharmacologic attenuation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with moderate to severe burns, increasing the ambient temperature from 25 to 33&ordm;C diminishes resting energy expenditure. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Environmental support'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with moderate to severe burns, a balanced physical therapy program to restore metabolic variables, prevent burn-wound contracture, improve body mass and increase muscle strength should be included in the treatment plan. (See",
"      <a class=\"local\" href=\"#H24\">",
"       'Exercise and adjunctive measures'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Because burn injuries cause one of the most intense and prolonged types of pain, pain management is important to attenuate the hypermetabolic response. Intravenous opioids, continuous or bolused, are most often used to relieve pain. (See",
"      <a class=\"local\" href=\"#H26\">",
"       'Analgesia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For stress-related hyperglycemia in burn patients without a past history of diabetes, we recommend intravenous treatment with insulin (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H28\">",
"       'Insulin'",
"      </a>",
"      above.) Insulin significantly lowered the incidence of sepsis and mortality in those patients with good glucose control compared with those who had poor control. The target glucose range for severely burned patients includes a morning glucose level of 130",
"      <span class=\"nowrap\">",
"       mg/dl",
"      </span>",
"      (7.2",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      and a daily average glucose level of 140",
"      <span class=\"nowrap\">",
"       mg/dl",
"      </span>",
"      (7.8",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      for at least 70 percent of the hospital admission. However, additional clinical trials are needed to define the ideal glucose levels for the treatment of critically ill, trauma, and severely burned adult patients.",
"     </li>",
"     <li>",
"      For patients with moderate to severe burns, we recommend",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/28/39364?source=see_link\">",
"       oxandrolone",
"      </a>",
"      &nbsp;(",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). Oxandrolone increases lean body mass gain and decreases hospital stay. (See",
"      <a class=\"local\" href=\"#H27\">",
"       'Oxandrolone'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For children with moderate to severe burns, we suggest treatment with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/49/8986?source=see_link\">",
"       propranolol",
"      </a>",
"      &nbsp;(",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). Propranolol attenuates the hypermetabolism and reverses muscle-protein catabolism. There is no evidence to support the routine use of propranolol in adult burn patients. (See",
"      <a class=\"local\" href=\"#H31\">",
"       'Propranolol'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/1\">",
"      Atiyeh BS, Gunn SW, Dibo SA. Metabolic implications of severe burn injuries and their management: a systematic review of the literature. World J Surg 2008; 32:1857.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/2\">",
"      Atiyeh BS, Gunn SW, Dibo SA. Nutritional and pharmacological modulation of the metabolic response of severely burned patients: review of the literature (part 1). Ann Burns Fire Disasters 2008; 21:63.",
"     </a>",
"    </li>",
"    <li>",
"     Herndon DN. Total Burn Care, 3rd edition, Saunders Elsevier, Philadelphia 2007.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/4\">",
"      Herndon DN, Tompkins RG. Support of the metabolic response to burn injury. Lancet 2004; 363:1895.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/5\">",
"      McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia. Crit Care Clin 2001; 17:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/6\">",
"      Hart DW, Wolf SE, Mlcak R, et al. Persistence of muscle catabolism after severe burn. Surgery 2000; 128:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/7\">",
"      American Burn Association/American College of Surgeons. Guidelines for the operation of burn centers. J Burn Care Res 2007; 28:134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/8\">",
"      Mlcak RP, Jeschke MG, Barrow RE, Herndon DN. The influence of age and gender on resting energy expenditure in severely burned children. Ann Surg 2006; 244:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/9\">",
"      Przkora R, Barrow RE, Jeschke MG, et al. Body composition changes with time in pediatric burn patients. J Trauma 2006; 60:968.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/10\">",
"      Dolecek R. Endocrine changes after burn trauma--a review. Keio J Med 1989; 38:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/11\">",
"      Jeffries MK, Vance ML. Growth hormone and cortisol secretion in patients with burn injury. J Burn Care Rehabil 1992; 13:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/12\">",
"      Klein GL, Bi LX, Sherrard DJ, et al. Evidence supporting a role of glucocorticoids in short-term bone loss in burned children. Osteoporos Int 2004; 15:468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/13\">",
"      GOODALL M, STONE C, HAYNES BW Jr. Urinary output of adrenaline and noradrenaline in severe thermal burns. Ann Surg 1957; 145:479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/14\">",
"      Coombes EJ, Batstone GF. Urine cortisol levels after burn injury. Burns Incl Therm Inj 1982; 8:333.",
"     </a>",
"    </li>",
"    <li>",
"     Norbury WB, Herndon DN. Modulation of the hypermetabolic response after burn injury. In: Total Burn Care, 3rd edition, Herndon DN (Ed), Saunders Elsevier, New York 2007. p.420.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/16\">",
"      Pereira CT, Herndon DN. The pharmacologic modulation of the hypermetabolic response to burns. Adv Surg 2005; 39:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/17\">",
"      Jeschke MG, Barrow RE, Herndon DN. Extended hypermetabolic response of the liver in severely burned pediatric patients. Arch Surg 2004; 139:641.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/18\">",
"      Deitch EA. Nutritional support of the burn patient. Crit Care Clin 1995; 11:735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/19\">",
"      Dickerson RN, Gervasio JM, Riley ML, et al. Accuracy of predictive methods to estimate resting energy expenditure of thermally-injured patients. JPEN J Parenter Enteral Nutr 2002; 26:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/20\">",
"      Demling RH, Seigne P. Metabolic management of patients with severe burns. World J Surg 2000; 24:673.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/21\">",
"      Sheridan RL. A great constitutional disturbance. N Engl J Med 2001; 345:1271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/22\">",
"      Pereira C, Murphy K, Jeschke M, Herndon DN. Post burn muscle wasting and the effects of treatments. Int J Biochem Cell Biol 2005; 37:1948.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/23\">",
"      Jeschke MG, Mlcak RP, Finnerty CC, et al. Burn size determines the inflammatory and hypermetabolic response. Crit Care 2007; 11:R90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/24\">",
"      Gauglitz GG, Herndon DN, Kulp GA, et al. Abnormal insulin sensitivity persists up to three years in pediatric patients post-burn. J Clin Endocrinol Metab 2009; 94:1656.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/25\">",
"      Wolfe RR. Review: acute versus chronic response to burn injury. Circ Shock 1981; 8:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/26\">",
"      Cuthbertson DP, Angeles Valero Zanuy MA, Le&oacute;n Sanz ML. Post-shock metabolic response. 1942. Nutr Hosp 2001; 16:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/27\">",
"      Galster AD, Bier DM, Cryer PE, Monafo WW. Plasma palmitate turnover in subjects with thermal injury. J Trauma 1984; 24:938.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/28\">",
"      Cree MG, Aarsland A, Herndon DN, Wolfe RR. Role of fat metabolism in burn trauma-induced skeletal muscle insulin resistance. Crit Care Med 2007; 35:S476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/29\">",
"      Childs C, Heath DF, Little RA, Brotherston M. Glucose metabolism in children during the first day after burn injury. Arch Emerg Med 1990; 7:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/30\">",
"      Gearhart MM, Parbhoo SK. Hyperglycemia in the critically ill patient. AACN Clin Issues 2006; 17:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/31\">",
"      Robinson LE, van Soeren MH. Insulin resistance and hyperglycemia in critical illness: role of insulin in glycemic control. AACN Clin Issues 2004; 15:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/32\">",
"      Wolfe RR, Herndon DN, Jahoor F, et al. Effect of severe burn injury on substrate cycling by glucose and fatty acids. N Engl J Med 1987; 317:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/33\">",
"      Carlson GL. Insulin resistance and glucose-induced thermogenesis in critical illness. Proc Nutr Soc 2001; 60:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/34\">",
"      Wolfe RR, Durkot MJ, Allsop JR, Burke JF. Glucose metabolism in severely burned patients. Metabolism 1979; 28:1031.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/35\">",
"      Cree MG, Zwetsloot JJ, Herndon DN, et al. Insulin sensitivity and mitochondrial function are improved in children with burn injury during a randomized controlled trial of fenofibrate. Ann Surg 2007; 245:214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/36\">",
"      Hunt DG, Ivy JL. Epinephrine inhibits insulin-stimulated muscle glucose transport. J Appl Physiol 2002; 93:1638.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/37\">",
"      Baracos V, Rodemann HP, Dinarello CA, Goldberg AL. Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1). A mechanism for the increased degradation of muscle proteins during fever. N Engl J Med 1983; 308:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/38\">",
"      Jahoor F, Desai M, Herndon DN, Wolfe RR. Dynamics of the protein metabolic response to burn injury. Metabolism 1988; 37:330.",
"     </a>",
"    </li>",
"    <li>",
"     Saffle JR, Graves C. Nutritional support of the burned patient. In: Total Burn Care, 3rd edition, Herndon DN (Ed), Saunders Elsevier, New York 2007. p.398.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/40\">",
"      DeFronzo RA, Jacot E, Jequier E, et al. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 1981; 30:1000.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/41\">",
"      McClave SA, Snider HL. Use of indirect calorimetry in clinical nutrition. Nutr Clin Pract 1992; 7:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/42\">",
"      Arora NS, Rochester DF. Respiratory muscle strength and maximal voluntary ventilation in undernourished patients. Am Rev Respir Dis 1982; 126:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/43\">",
"      Rutan RL, Herndon DN. Growth delay in postburn pediatric patients. Arch Surg 1990; 125:392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/44\">",
"      Ong YS, Samuel M, Song C. Meta-analysis of early excision of burns. Burns 2006; 32:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/45\">",
"      Munster AM, Smith-Meek M, Sharkey P. The effect of early surgical intervention on mortality and cost-effectiveness in burn care, 1978-91. Burns 1994; 20:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/46\">",
"      Prasanna M, Mishra P, Thomas C. Delayed primary closure of the burn wounds. Burns 2004; 30:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/47\">",
"      Atiyeh BS, Dham R, Kadry M, et al. Benefit-cost analysis of moist exposed burn ointment. Burns 2002; 28:659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/48\">",
"      Ramzy PI, Barret JP, Herndon DN. Thermal injury. Crit Care Clin 1999; 15:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/49\">",
"      Blome-Eberwein S, Jester A, Kuentscher M, et al. Clinical practice of glycerol preserved allograft skin coverage. Burns 2002; 28 Suppl 1:S10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/50\">",
"      Garfein ES, Orgill DP, Pribaz JJ. Clinical applications of tissue engineered constructs. Clin Plast Surg 2003; 30:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/51\">",
"      Bannasch H, F&ouml;hn M, Unterberg T, et al. Skin tissue engineering. Clin Plast Surg 2003; 30:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/52\">",
"      Pellegrini G, Ranno R, Stracuzzi G, et al. The control of epidermal stem cells (holoclones) in the treatment of massive full-thickness burns with autologous keratinocytes cultured on fibrin. Transplantation 1999; 68:868.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/53\">",
"      Supp DM, Boyce ST. Engineered skin substitutes: practices and potentials. Clin Dermatol 2005; 23:403.",
"     </a>",
"    </li>",
"    <li>",
"     Muller M, Gahankari D, Herndon DN. Operative wound management. In: Total Burn Care, 3rd edition, Herndon DN (Ed), Saunders Elsevier, New York 2007. p.177.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/55\">",
"      Tompkins RG, Burke JF. Progress in burn treatment and the use of artificial skin. World J Surg 1990; 14:819.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/56\">",
"      Burke JF, Yannas IV, Quinby WC Jr, et al. Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury. Ann Surg 1981; 194:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/57\">",
"      Yannas IV, Burke JF, Orgill DP, Skrabut EM. Wound tissue can utilize a polymeric template to synthesize a functional extension of skin. Science 1982; 215:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/58\">",
"      Yannas IV, Burke JF, Warpehoski M, et al. Prompt, long-term functional replacement of skin. Trans Am Soc Artif Intern Organs 1981; 27:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/59\">",
"      Tsai CC, Lin SD, Lai CS, Lin TM. The use of composite acellular allodermis-ultrathin autograft on joint area in major burn patients--one year follow-up. Kaohsiung J Med Sci 1999; 15:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/60\">",
"      Lattari V, Jones LM, Varcelotti JR, et al. The use of a permanent dermal allograft in full-thickness burns of the hand and foot: a report of three cases. J Burn Care Rehabil 1997; 18:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/61\">",
"      Wainwright D, Madden M, Luterman A, et al. Clinical evaluation of an acellular allograft dermal matrix in full-thickness burns. J Burn Care Rehabil 1996; 17:124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/62\">",
"      Sheridan R, Choucair R, Donelan M, et al. Acellular allodermis in burns surgery: 1-year results of a pilot trial. J Burn Care Rehabil 1998; 19:528.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/63\">",
"      Hohlfeld J, de Buys Roessingh A, Hirt-Burri N, et al. Tissue engineered fetal skin constructs for paediatric burns. Lancet 2005; 366:840.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/64\">",
"      Branski LK, Gauglitz GG, Herndon DN, Jeschke MG. A review of gene and stem cell therapy in cutaneous wound healing. Burns 2009; 35:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/65\">",
"      Newsome TW, Mason AD Jr, Pruitt BA Jr. Weight loss following thermal injury. Ann Surg 1973; 178:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/66\">",
"      Hart DW, Wolf SE, Chinkes DL, et al. Effects of early excision and aggressive enteral feeding on hypermetabolism, catabolism, and sepsis after severe burn. J Trauma 2003; 54:755.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/67\">",
"      Herndon DN, Barrow RE, Stein M, et al. Increased mortality with intravenous supplemental feeding in severely burned patients. J Burn Care Rehabil 1989; 10:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/68\">",
"      Wasiak J, Cleland H, Jeffery R. Early versus delayed enteral nutrition support for burn injuries. Cochrane Database Syst Rev 2006; :CD005489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/69\">",
"      Curreri PW, Richmond D, Marvin J, Baxter CR. Dietary requirements of patients with major burns. J Am Diet Assoc 1974; 65:415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/70\">",
"      Allard JP, Pichard C, Hoshino E, et al. Validation of a new formula for calculating the energy requirements of burn patients. JPEN J Parenter Enteral Nutr 1990; 14:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/71\">",
"      Hildreth MA, Herndon DN, Desai MH, Broemeling LD. Current treatment reduces calories required to maintain weight in pediatric patients with burns. J Burn Care Rehabil 1990; 11:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/72\">",
"      Herndon DN, Curreri PW. Metabolic response to thermal injury and its nutritional support. Cutis 1978; 22:501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/73\">",
"      Lam NN, Tien NG, Khoa CM. Early enteral feeding for burned patients--an effective method which should be encouraged in developing countries. Burns 2008; 34:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/74\">",
"      Garrel DR, Razi M, Larivi&egrave;re F, et al. Improved clinical status and length of care with low-fat nutrition support in burn patients. JPEN J Parenter Enteral Nutr 1995; 19:482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/75\">",
"      Mochizuki H, Trocki O, Dominioni L, et al. Optimal lipid content for enteral diets following thermal injury. JPEN J Parenter Enteral Nutr 1984; 8:638.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/76\">",
"      Barret JP, Jeschke MG, Herndon DN. Fatty infiltration of the liver in severely burned pediatric patients: autopsy findings and clinical implications. J Trauma 2001; 51:736.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/77\">",
"      Aarsland A, Chinkes D, Wolfe RR. Contributions of de novo synthesis of fatty acids to total VLDL-triglyceride secretion during prolonged hyperglycemia/hyperinsulinemia in normal man. J Clin Invest 1996; 98:2008.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/78\">",
"      Herndon DN, Nguyen TT, Wolfe RR, et al. Lipolysis in burned patients is stimulated by the beta 2-receptor for catecholamines. Arch Surg 1994; 129:1301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/79\">",
"      Zawacki BE, Spitzer KW, Mason AD Jr, Johns LA. Does increased evaporative water loss cause hypermetabolism in burned patients? Ann Surg 1970; 171:236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/80\">",
"      Wilmore DW, Mason AD Jr, Johnson DW, Pruitt BA Jr. Effect of ambient temperature on heat production and heat loss in burn patients. J Appl Physiol 1975; 38:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/81\">",
"      Cucuzzo NA, Ferrando A, Herndon DN. The effects of exercise programming vs traditional outpatient therapy in the rehabilitation of severely burned children. J Burn Care Rehabil 2001; 22:214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/82\">",
"      Murphy KD, Lee JO, Herndon DN. Current pharmacotherapy for the treatment of severe burns. Expert Opin Pharmacother 2003; 4:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/83\">",
"      Hedderich R, Ness TJ. Analgesia for trauma and burns. Crit Care Clin 1999; 15:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/84\">",
"      Hart DW, Wolf SE, Ramzy PI, et al. Anabolic effects of oxandrolone after severe burn. Ann Surg 2001; 233:556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/85\">",
"      Demling RH, Orgill DP. The anticatabolic and wound healing effects of the testosterone analog oxandrolone after severe burn injury. J Crit Care 2000; 15:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/86\">",
"      Wolf SE, Edelman LS, Kemalyan N, et al. Effects of oxandrolone on outcome measures in the severely burned: a multicenter prospective randomized double-blind trial. J Burn Care Res 2006; 27:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/87\">",
"      Demling RH, DeSanti L. The rate of restoration of body weight after burn injury, using the anabolic agent oxandrolone, is not age dependent. Burns 2001; 27:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/88\">",
"      Jeschke MG, Finnerty CC, Suman OE, et al. The effect of oxandrolone on the endocrinologic, inflammatory, and hypermetabolic responses during the acute phase postburn. Ann Surg 2007; 246:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/89\">",
"      Murphy KD, Thomas S, Mlcak RP, et al. Effects of long-term oxandrolone administration in severely burned children. Surgery 2004; 136:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/90\">",
"      Porro LJ, Herndon DN, Rodriguez NA, et al. Five-year outcomes after oxandrolone administration in severely burned children: a randomized clinical trial of safety and efficacy. J Am Coll Surg 2012; 214:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/91\">",
"      Suman OE, Thomas SJ, Wilkins JP, et al. Effect of exogenous growth hormone and exercise on lean mass and muscle function in children with burns. J Appl Physiol 2003; 94:2273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/92\">",
"      Ferrando AA, Chinkes DL, Wolf SE, et al. A submaximal dose of insulin promotes net skeletal muscle protein synthesis in patients with severe burns. Ann Surg 1999; 229:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/93\">",
"      Pierre EJ, Barrow RE, Hawkins HK, et al. Effects of insulin on wound healing. J Trauma 1998; 44:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/94\">",
"      Thomas SJ, Morimoto K, Herndon DN, et al. The effect of prolonged euglycemic hyperinsulinemia on lean body mass after severe burn. Surgery 2002; 132:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/95\">",
"      Zhang XJ, Chinkes DL, Wolf SE, Wolfe RR. Insulin but not growth hormone stimulates protein anabolism in skin wound and muscle. Am J Physiol 1999; 276:E712.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/96\">",
"      Jeschke MG, Klein D, Bolder U, Einspanier R. Insulin attenuates the systemic inflammatory response in endotoxemic rats. Endocrinology 2004; 145:4084.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/97\">",
"      Jeschke MG, Klein D, Herndon DN. Insulin treatment improves the systemic inflammatory reaction to severe trauma. Ann Surg 2004; 239:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/98\">",
"      Jeschke MG, Rensing H, Klein D, et al. Insulin prevents liver damage and preserves liver function in lipopolysaccharide-induced endotoxemic rats. J Hepatol 2005; 42:870.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/99\">",
"      Klein D, Schubert T, Horch RE, et al. Insulin treatment improves hepatic morphology and function through modulation of hepatic signals after severe trauma. Ann Surg 2004; 240:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/100\">",
"      Jeschke MG, Kulp GA, Kraft R, et al. Intensive insulin therapy in severely burned pediatric patients: a prospective randomized trial. Am J Respir Crit Care Med 2010; 182:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/101\">",
"      Jeschke MG, Kraft R, Emdad F, et al. Glucose control in severely thermally injured pediatric patients: what glucose range should be the target? Ann Surg 2010; 252:521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/102\">",
"      Meier JJ, Weyhe D, Michaely M, et al. Intravenous glucagon-like peptide 1 normalizes blood glucose after major surgery in patients with type 2 diabetes. Crit Care Med 2004; 32:848.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/103\">",
"      Deane AM, Chapman MJ, Fraser RJ, et al. The effect of exogenous glucagon-like peptide-1 on the glycaemic response to small intestinal nutrient in the critically ill: a randomised double-blind placebo-controlled cross over study. Crit Care 2009; 13:R67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/104\">",
"      Mecott GA, Herndon DN, Kulp GA, et al. The use of exenatide in severely burned pediatric patients. Crit Care 2010; 14:R153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/105\">",
"      Dandona P, Chaudhuri A, Mohanty P, Ghanim H. Anti-inflammatory effects of insulin. Curr Opin Clin Nutr Metab Care 2007; 10:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/106\">",
"      Gore DC, Wolf SE, Herndon DN, Wolfe RR. Metformin blunts stress-induced hyperglycemia after thermal injury. J Trauma 2003; 54:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/107\">",
"      DeFronzo RA, Goodman AM. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group. N Engl J Med 1995; 333:541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/108\">",
"      Stumvoll M, Nurjhan N, Perriello G, et al. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med 1995; 333:550.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/109\">",
"      Gore DC, Herndon DN, Wolfe RR. Comparison of peripheral metabolic effects of insulin and metformin following severe burn injury. J Trauma 2005; 59:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/110\">",
"      Bailey CJ, Turner RC. Metformin. N Engl J Med 1996; 334:574.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/111\">",
"      Aili Low JF, Barrow RE, Mittendorfer B, et al. The effect of short-term growth hormone treatment on growth and energy expenditure in burned children. Burns 2001; 27:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/112\">",
"      Branski LK, Herndon DN, Barrow RE, et al. Randomized controlled trial to determine the efficacy of long-term growth hormone treatment in severely burned children. Ann Surg 2009; 250:514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/113\">",
"      Ramirez RJ, Wolf SE, Barrow RE, Herndon DN. Growth hormone treatment in pediatric burns: a safe therapeutic approach. Ann Surg 1998; 228:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/114\">",
"      Jeschke MG, Herndon DN, Wolf SE, et al. Recombinant human growth hormone alters acute phase reactant proteins, cytokine expression, and liver morphology in burned rats. J Surg Res 1999; 83:122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/115\">",
"      Wu X, Herndon DN, Wolf SE. Growth hormone down-regulation of Interleukin-1beta and Interleukin-6 induced acute phase protein gene expression is associated with increased gene expression of suppressor of cytokine signal-3. Shock 2003; 19:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/116\">",
"      Jeschke MG, Chrysopoulo MT, Herndon DN, Wolf SE. Increased expression of insulin-like growth factor-I in serum and liver after recombinant human growth hormone administration in thermally injured rats. J Surg Res 1999; 85:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/117\">",
"      Hart DW, Herndon DN, Klein G, et al. Attenuation of posttraumatic muscle catabolism and osteopenia by long-term growth hormone therapy. Ann Surg 2001; 233:827.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/118\">",
"      Herndon DN, Barrow RE, Kunkel KR, et al. Effects of recombinant human growth hormone on donor-site healing in severely burned children. Ann Surg 1990; 212:424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/119\">",
"      Herndon DN, Hart DW, Wolf SE, et al. Reversal of catabolism by beta-blockade after severe burns. N Engl J Med 2001; 345:1223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/120\">",
"      Arbabi S, Ahrns KS, Wahl WL, et al. Beta-blocker use is associated with improved outcomes in adult burn patients. J Trauma 2004; 56:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/121\">",
"      Baron PW, Barrow RE, Pierre EJ, Herndon DN. Prolonged use of propranolol safely decreases cardiac work in burned children. J Burn Care Rehabil 1997; 18:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/122\">",
"      Jeschke MG, Norbury WB, Finnerty CC, et al. Propranolol does not increase inflammation, sepsis, or infectious episodes in severely burned children. J Trauma 2007; 62:676.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/123\">",
"      Aarsland A, Chinkes D, Wolfe RR, et al. Beta-blockade lowers peripheral lipolysis in burn patients receiving growth hormone. Rate of hepatic very low density lipoprotein triglyceride secretion remains unchanged. Ann Surg 1996; 223:777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/124\">",
"      Gore DC, Honeycutt D, Jahoor F, et al. Propranolol diminishes extremity blood flow in burned patients. Ann Surg 1991; 213:568.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/51/22330/abstract/125\">",
"      Pereira CT, Jeschke MG, Herndon DN. Beta-blockade in burns. Novartis Found Symp 2007; 280:238.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 818 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-122.72.76.133-F1B7A60FFB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_51_22330=[""].join("\n");
var outline_f21_51_22330=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H32\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      HYPERMETABOLIC CHANGES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Definition",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Frequency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Etiology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Duration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      PATTERNS OF METABOLIC REGULATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Ebb phase",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Flow phase",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      GLUCOSE METABOLISM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Normal response",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Stress response",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      PROTEIN AND LIPID METABOLISM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      THERAPEUTIC APPROACHES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      NONPHARMACOLOGIC ATTENUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Early wound closure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Biological and synthetic substrates",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Nutritional support",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Energy expenditure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Energy expenditure formulas",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Essential fatty acids",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Glycemic targets",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Environmental support",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Exercise and adjunctive measures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      PHARMACOLOGIC ATTENUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Analgesia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Oxandrolone",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Insulin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Metformin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Recombinant human growth hormone",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Propranolol",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/42/38569?source=related_link\">",
"      Acute phase reactants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/17/275?source=related_link\">",
"      Beta blockers in the treatment of hyperthyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/23/34169?source=related_link\">",
"      Burn pain: Principles of pharmacologic and nonpharmacologic management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/22/15716?source=related_link\">",
"      Evaluating nutritional support for moderate to severe burn patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/37/28249?source=related_link\">",
"      Glucocorticoid effects on the immune system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/23/28023?source=related_link\">",
"      Glycemic control and intensive insulin therapy in critical illness",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/35/43577?source=related_link\">",
"      Initial management of blood glucose in type 2 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/58/25511?source=related_link\">",
"      Insulin action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/57/28567?source=related_link\">",
"      Insulin resistance: Definition and clinical spectrum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/46/41702?source=related_link\">",
"      Insulin secretion and pancreatic beta-cell function",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/39/3704?source=related_link\">",
"      Major side effects of beta blockers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/39/26233?source=related_link\">",
"      Management of diabetes mellitus in hospitalized patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/6/34921?source=related_link\">",
"      Mast cell derived mediators",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/26/38312?source=related_link\">",
"      Metformin in the treatment of diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/32/13831?source=related_link\">",
"      Nutrition support in critically ill patients: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/17/34073?source=related_link\">",
"      Nutrition support in critically ill patients: Enteral nutrition",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/58/8102?source=related_link\">",
"      Nutrition support in critically ill patients: Parenteral nutrition",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/8/11401?source=related_link\">",
"      Nutritional demands and enteral formulas for moderate to severe burn patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/7/4215?source=related_link\">",
"      Overview of nutritional support for moderate to severe burn patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/50/38695?source=related_link\">",
"      Paradigm-based treatment approaches for burn pain control",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/32/6664?source=related_link\">",
"      Perioperative nutritional support",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29638?source=related_link\">",
"      Physiologic response to hypoglycemia in normal subjects and patients with diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/8/4231?source=related_link\">",
"      Role of cytokines in the immune system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/58/6056?source=related_link\">",
"      The adaptive cellular immune response",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/62/27624?source=related_link\">",
"      The humoral immune response",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/55/40825?source=related_link\">",
"      Tumor necrosis factor-alpha inhibitors: An overview of adverse effects",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_51_22331="Performance of PEF maneuver";
var content_f21_51_22331=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F53856&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F53856&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Performance of peak flow maneuver",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Explain and demonstrate the test*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Zero the PEF monitor, if necessary",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stand up straight",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Inhale completely; the inhalation should be rapid but",
"not forced",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Place PEF monitor in mouth and close lips around the",
"mouthpiece&bull;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Exhale with maximal force&Delta;",
"as soon as lips are",
"sealed around mouthpiece&loz;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Write down results",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Repeat two or more times (three total)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Record all three values",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Not necessary if at home.",
"     <br>",
"      &bull; Nose clips are not necessary.",
"      <br>",
"       &Delta; Make sure subject understands to make full use of respiratory muscles, not just use the diaphram as a \"toot\" or \"mouth\" maneuver.",
"       <br>",
"        &loz; D'Angelo and coworkers [65] have reported that PEF is reduced when, during the inspiratory maneuver, there is a four to six second pause at TLC before beginning exhalation. It is not known if similar changes will be observed with portable peak flow meters.",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_51_22331=[""].join("\n");
var outline_f21_51_22331=null;
var title_f21_51_22332="Definitions euthanasia PAS";
var content_f21_51_22332=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F50242&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F50242&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Definitions of euthanasia and physician-assisted suicide",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Term",
"       </td>",
"       <td class=\"subtitle1\">",
"        Definition",
"       </td>",
"       <td class=\"subtitle1\">",
"        Status",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Voluntary active euthanasia",
"       </td>",
"       <td>",
"        When the physician or someone else administers medications,",
"such as narcotics, or other intervention to intentionally cause the",
"patient's death at the patient's explicit request with full informed",
"consent.",
"       </td>",
"       <td>",
"        Legal in the Netherlands and Belgium. Had been legal in the Northern Territory, Australia.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Involuntary active euthanasia",
"       </td>",
"       <td>",
"        When a physician or someone else administers medications,",
"such as narcotics, or other intervention to intentionally cause the",
"patient's death when the patient was competent but without the",
"patient's explicit request and/or full informed consent. The patient",
"may never have been asked about euthanasia.",
"       </td>",
"       <td>",
"        Not legal anywhere.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Non-voluntary active euthanasia",
"       </td>",
"       <td>",
"        When the physician or someone else administers medications,",
"such as narcotics, or other intervention to intentionally cause the",
"patient's death when the patient was mentally incompetent and could not",
"explicitly request euthanasia. The patient may have been in a coma.",
"       </td>",
"       <td>",
"        Not legal anywhere.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Terminating life-sustaining treatments (passive euthanasia)",
"       </td>",
"       <td>",
"        When the physician withholds or withdraws life-sustaining",
"treatments, such as a respirator, vasopressors, or artificial",
"nutrition, from the patient with the patient or proxy's consent. (This",
"should not be called euthanasia. This is an historical relic and",
"misnomer).",
"       </td>",
"       <td>",
"        Legal and ethical in the United States and most other countries.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Indirect euthanasia",
"       </td>",
"       <td>",
"        When the physician administers narcotics or other medications",
"to relieve pain or other symptoms with the incidental consequence of",
"causing sufficient respiratory depression or other side effects to",
"increase the risk of the patient's death. (This should not be called",
"euthanasia. This is an historical relic and misnomer).",
"       </td>",
"       <td>",
"        Legal and ethical in the United States and most other countries.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Physician-assisted suicide",
"       </td>",
"       <td>",
"        When the physician provides medication, a prescription,",
"information, or other interventions to a patient with the understanding",
"that the patient intends to use them to commit suicide.",
"       </td>",
"       <td>",
"        Legal in Oregon, the Netherlands, Belgium, and Switzerland.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_51_22332=[""].join("\n");
var outline_f21_51_22332=null;
var title_f21_51_22333="Etiologies of polyradiculopathy";
var content_f21_51_22333=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F81525&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F81525&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Etiologies of polyradiculopathy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Structural",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist_other_start\">",
"            1. Spinal stenosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            a. Congenital",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent3\">",
"            i. Achondroplasia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent3\">",
"            ii. Hereditary (idiopathic)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            b. Acquired",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent3\">",
"            i. Ankylosing spondylitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent3\">",
"            ii. Degenerative",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent3\">",
"            iii. Iatrogenic",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent3\">",
"            iv. Paget disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent3\">",
"            v. Post-traumatic",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist_other_start\">",
"            2. Tethered cord syndrome",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist_other_start\">",
"            3. Primary tumors",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            a. Dermoid",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            b. Ependymoma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            c. Epidermoid",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            d. Ganglioneuroma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            e. Hemangioblastoma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            f. Lipoma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            g. Lymphoma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            h. Neurofibroma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            i. Osteoma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            j. Paraganglioma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            k. Plasmacytoma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            l. Schwannoma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist_other_start\">",
"            4. Leptomeningeal metastasis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist_other_start\">",
"            5. Dural ectasia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist_other_start\">",
"            6. Lumbosacral spinal cysts",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Nonstructural",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist_other_start\">",
"            1. Diabetes",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            a. Diabetic amyotrophy",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            b. Thoracic radiculopathy",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist_other_start\">",
"            2. Lyme disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist_other_start\">",
"            3. AIDS-related",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            a. Cryptococcal infection",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            b. Cytomegalovirus infection",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            c. Lymphomatous meningitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            d. Mycobacterial infection",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            e. Treponemal infection",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist_other_start\">",
"            4. Arachnoiditis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            a. Idiopathic",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            b. Neurocysticercosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            c. Post myelography",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            d. Post-traumatic",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            e. Subarachnoid hemorrhage",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist_other_start\">",
"            5. Sarcoidosis",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Seward Rutkove, MD and Andrew Tarulli, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_51_22333=[""].join("\n");
var outline_f21_51_22333=null;
var title_f21_51_22334="Diverticulitis BE";
var content_f21_51_22334=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F55313&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F55313&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Diverticulitis of sigmoid colon",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 276px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Single contrast barium enema reveals spasm, rigidity, mural thickening, and lack of distensibility of a focal segment of sigmoid colon in a patient with sigmoid diverticulitis. Note the presence of a small diverticulum (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Norman Joffe, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_51_22334=[""].join("\n");
var outline_f21_51_22334=null;
var title_f21_51_22335="Flock workers lung CT - Micronodular pattern";
var content_f21_51_22335=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F60591&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F60591&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Flock worker's lung CT - Micronodular pattern",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 255px; height: 240px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Prone CT of the chest shows a micronodular pattern.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of David Kern, MD and Robert Crausman, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_51_22335=[""].join("\n");
var outline_f21_51_22335=null;
